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ABSTRACT 
Flaviviruses are responsible for a myriad of epidemics globally. Factors like 
movement and climate change perpetuate their spread making control rather 
challenging. The understanding of host-virus interactions is therefore 
cornerstone in attempts to produce efficient vaccines and/or therapies.  
The host immune system is indispensable in fighting infections but viruses have 
developed evasion strategies which abrogate the response that would otherwise 
function in virus clearance.  
The unfolded protein response (UPR), an intrinsic cellular proteostasis pathway is 
increasingly associated with innate immunity in response to cellular insults 
including viral infection. UPR activation by external stimuli elicits an earlier 
induction of IFNβ and antiviral ISGs suggesting UPR as a priming event that 
potentiates a more robust response against flaviviruses.  
Prerequisite to the core of this study, an analysis of the effects of TM and TG 
(UPR chemical inducers) as used in our current experimental settings show that 
they are only cytostatic but not cytotoxic.  
Afterwards, I delve into the search for alternative UPR inducers as potential 
alternatives for the ones currently in use. I show that E, NS1 and NS2B proteins 
of TBEV can induce UPR and several antiviral ISGs when ectopically expressed, an 
effect that inhibits TBEV in infection.  
 Of the three proteins studied, NS2B seems to be the most potent inducer of UPR 
and antiviral ISGs. Furthermore, expression of NS2B together with RIG-I 
augments the IFNβ promoter activity suggesting a possible role in innate 
signaling independent of infection. 
 The findings of this work open up possible avenues that require further 
investigation particularly in the case of NS2B, which is not a well-documented 
flavivirus protein apart from the context of its function as a protease cofactor. 
The mechanism by which it induces ER stress is especially intriguing because 
unlike E and NS1 proteins, it is not a glycoprotein. 
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Introduction 
 
1.1 Family Flaviviridae 
Flaviviridae is a large family of small (40 to 60 nm diameter), enveloped viruses 
with a linear, non-segmented, single-stranded RNA of positive polarity. The 
genome of members in this family ranges from 9 to 13kbp and their surface 
proteins are arranged in an icosahedral-like symmetry (Lindenbach and Rice, 
2001; Wengler et al., 1978; Zhang et al., 2003). The word Flaviviridae is derived 
from “Flavus” which is Latin for “yellow”, this came due to the importance of the 
Yellow Fever virus, the prototype virus in this family and the genus Flavivirus; 
that was the first proven human pathogen, isolated in 1927 in the Rhesus 
monkey (Macaca mulatta), through the inoculation of blood from an African 
patient (Stock et al., 2013, Strode G. 1951)  
There currently exist four genera in this family (Fig. 1).  
1.1.1 Flavivirus 
This genus is largely made up of arboviruses, that is, their transmission to 
vertebrate hosts is through arthropod vectors mainly mosquitoes and ticks. 
However, there also exist viruses in this genus with no known vectors. The 5’ end 
of the genome possesses a type I cap (m7GpppAmp) not seen in the other genera 
and the 3’ end lacks terminal polyadenylation (Simmonds et al., (ICTV), 2017). 
The genus Flavivirus will be discussed in more detail in the following paragraphs. 
1.1.2 Hepacivirus 
This genus contains both primate (Hepacivirus C) and non-primate viruses. Non-
primate viruses have been described in horses, donkeys, colobus monkeys as 
well as in rodents and bats. Hepacivirus C has been widely characterized 
virologically and clinically more than all its counterparts in the genus. A general 
distinctive feature of members of this genus as compared to other members in 
the family is the limited propagative ability of Hepaciviruses in cell culture. The 5’ 
UTR of Hepacivirus C contains a type IV IRES structural element that directs cap-
independent translation. (Simmonds et al., (ICTV), 2017) 
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1.1.3 Pegivirus 
This genus in contrast to the Hepaciviruses does not encode a core protein and 
instead of the type IV IRES structural element, it employs a type III IRES in the 
cap independent translation of the genomic RNA. Pegiviruses can be found in a 
wide variety of humans, non-human primates, pigs, horses as well as rodents and 
bats (Simmonds et al., (ICTV), 2017). 
1.1.4 Pestivirus 
Translation of the Pestivirus genomic RNA is cap-independent and initiated by a 
type IV internal ribosomal entry site of about 370-385 nucleotides within the 5’-
non- coding region of the virus genomic RNA and the 3ʹ-NCR, with about 185–
273 nucleotides, is complex and contains a region with variable sequences and a 
highly conserved terminal region. The genome encodes for four structural and 8 
non-structural proteins. Pestiviruses infect pigs and ruminants but have also 
been detected in wild ruminants and wild boar (Smith et al., 2017, Simmonds et 
al., (ICTV), 2017)  
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Figure 1: Flaviviridae phylogenetic characteristics and basic features of reference genomes 
(Chen S. et al., 2017) 
1.2 Flaviviruses 
Majority of viruses in the genus flavivirus are arthropod-borne pathogens that is, 
transmitted between arthropods (mainly ticks and mosquitoes) and vertebrates 
also referred to as dual-host viruses (Blitvich and Firth, 2015). With over 40 
human-tropic viruses most of which are mosquito-borne, Flavivirus is an 
important genus in the family Flaviviridae because of its members’ global 
distribution, most of them considered important human and veterinary 
pathogens responsible for a myriad of haemorrhagic fevers and encephalitides 
that have been considered global public health threats. One example is the 
dengue virus (DENV), reported to cause approximately 390 million cases globally  
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per year (Bhatt et al., 2013). In addition to ticks and mosquito-borne viruses, 
there exists viruses with no-known vectors also termed vertebrate-specific 
viruses, these are isolated from rodents and bats, as well as insect-specific 
flaviviruses which have only been known to infect insect cells but not 
mammalian cells (Kenney et al., 2014; Blitvich and Firth, 2015; Bolling et al., 
2015). Some of the most important flaviviruses include Yellow fever virus (YFV), 
dengue virus (DENV 1-4), Japanese encephalitis virus (JEV), West Nile virus 
(WNV), Zika virus (ZIKV) and Tick-borne encephalitis virus (TBEV), 
which is endemic in Europe and parts of Asia. 
There is a constant spread of flaviviruses to new geographical areas where they 
never existed before such as the recent re-emergence of WNV and Zika virus in 
the Americas in 1999 and 2015, respectively (Asnis et al., 2000; Nash et al., 2001; 
Fauci et al., 2016; Petersen et al., 2016).  
Despite wide deployment of the YFV-17D vaccine in many African countries since 
2006, in 2016, new YFV epidemics occurred in Angola and DR Congo resulting to 
about 965 confirmed cases and 400 mortalities. According to WHO, about 27 
countries in Africa remain at risk of epidemics despite the current efforts 
(https://www.afro.who.int/health-topics/yellow-fever) 
This like many other epidemics are highly contributed by factors such as 
urbanization, transportation, poor public health infrastructure especially in the 
developing world, land use changes as well as natural factors, such as genetic 
changes in the viruses, host-vector relationships, bird migration and global 
climate changes (Mackenzie et al., 2004).  
Due to the close relationships among flaviviruses and the general rapid mutation 
rates of RNA viruses, there is a general problem in specific diagnosis, as well as a 
general lack of approved and/or efficient treatments and/or vaccines. 
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There exist effective, licensed vaccines against JEV, TBEV and the 17D vaccine 
against Yellow fever virus (YFV), which is the “gold standard” of successful 
vaccines and has severally been declared as the most efficient live attenuated 
vaccines ever generated to date (Fernandez-Garcia et al., 2016) 
1.2.1 Flavivirus life cycle (Fig. 3) 
Most of the flavivirus life cycle is largely inferred to from collective studies done 
on multiple flaviviruses especially Dengue virus 
1.2.1.1 Attachment and entry 
Binding of the virus is mediated by the viral large surface E glycoprotein and 
putative receptors on target cells. Additionally, some attachment factors such as 
the heparin sulphate, a factor present in many cell types have been shown to be 
involved in the initial stages of virus attachment in several flaviviruses. TIM and 
TAM proteins are coreceptor families identified to function as entry factors in 
DENV (Meertens et al., 2012).  
Other attachment factors documented to be utilized by flaviviruses include the 
ER chaperone protein GRP78/BiP which facilitates entry of JEV (Nain et al., 2017), 
heat shock proteins 70 and 90, laminin, ICAM-3 and CD14 (Smit et al., 2011). The 
virus is then taken up by receptor-mediated endocytosis via clathrin-coated pits 
and then virions are trafficked to prelysosomal endocytic compartments of the 
host cell. The acidic pH in these vesicles induces a conformational change and 
reorganization of the viral envelope protein E from dimers, dissociation into 
monomers and then reformation into trimers (Allison et al., 1995). Some 
identified receptors and entry strategies of DENV, YFV, ZIKV and JEV have been 
reviewed by Laureti et al., 2018 
While not much is known about the uncoating process, it is thought that the 
conformational change at this stage is key in the fusion of the viral proteins and 
endosomal membrane, a process that results in the uncoating and release of the 
viral nucleocapsid into the host cytoplasm (Heinz and Allison, 2003).  
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1.2.1.2 Translation and polyprotein processing 
Translation is cap-dependent, occurs in the ER, is coupled with replication and 
initiates by ribosomal scanning. After uncoating, the positive, capped RNA viral 
genome (being an mRNA) allows for direct translation of the single open reading 
frame in the Endoplasmic reticulum to produce a single precursor polyprotein of 
approximately 3400 amino acids that is further co- and post-translationally 
processed by both virus-encoded NS2B/3 protease and host signalases into 3 
structural (Capsid, Envelope and the pre-Membrane which matures into the 
Membrane) and 7 non-structural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B, 
NS5) (Fig.2).  
The 5’ end contains the structural proteins followed by the non-structural 
proteins stretching out until the 3’ end. It has been previously suggested that 
translation competency may determine infectivity in flaviviruses and they 
therefore use several mechanisms to facilitate that with some specialized 
structures within the 5’ and 3’ non-coding regions, mutations the 3’UTR in 
DENV2 has been shown to influence the RNA structure and changes the 
translation efficiency and the ultimate infectivity phenotype (Edgil et al., 2003) 
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Figure 2: Schematic representation of the flavivirus polyprotein and its cleavage products 
(Fernandez-Garcia et al., 2009) 
1.2.1.3 Replication 
The process of replication occurs within invaginations of the ER membrane called 
replication vesicles. Replication is catalyzed by the virus-encoded RNA 
dependent RNA polymerase activity of NS5 and is typically benchmarked by the 
production and accumulation of double-stranded RNA (dsRNA) intermediates 
that are classical markers of flaviviral replication (Paul and Bartenschlager, 2015). 
The process begins with the production of first negative strand copies that are 
further used as templates in proceeding rounds of replication yielding new 
positive strands that serve as the genome packaged into newly formed viral 
particles but also for more rounds of replication. During polyprotein synthesis, 
the surface proteins prM and E are translocated into the ER lumen and released 
by host cell signalase (Mandl, 2005).  
NS1 also translocates into the ER lumen once cleaved from the polypeptide and 
undergoes dimerization there, this dimeric form is ER-associated while the 
hexameric form, whose synthesis mechanism is unclear moves further along the  
 
		 	 	
	
	 9	
Introduction 
 
Golgi secretory pathway and is the circulating form.( as reviewed by Yap et 
al.,2017) 
1.2.1.4 Assembly and Budding 
The process of replication is closely related and somewhat intertwined with that 
of virus assembly both spatially and temporally. Additionally, it has been 
suggested that only actively replicated RNA gets packaged and this plays a role in 
the infectivity of the virus (Khromykh et al., 2001) The RNA genome is packaged 
by the Capsid protein in nucleocapsids on the cytoplasmic side of the ER 
membrane, a process coordinated with the viral envelope assembly that is 
acquired by budding of the nucleocapsid into the ER. Nucleocapsids are then 
transported into the lumen of the endoplasmic reticulum at the replication 
vesicle pore during formation of the prM-E lipid envelope (Roby et al., 2012).  
1.2.1.5 Maturation and virion release 
Assembled, immature virions are trafficked to the Trans-Golgi Network (TGN) 
where they undergo reversible conformational changes due to the low pH 
rendering them accessible to furin, a cellular protease abundant in the TGN and 
responsible for the proteolytic cleavage of the prM and the ultimate dissociation 
of its pr peptide. This event is the hallmark of virion maturation and marker for 
infection-competent virions. Mature virions finally bud out of the cell by 
exocytosis (Yu et al., 2008). 
Only properly cleaved progeny virions, with a nucleocapsid containing a full 
genome copy can successfully infect other cells in proceeding rounds of infection 
(Chambers et al., 2003) 
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  Figure 3: An overview of the TBEV life cycle (Pulliknen et  al., 2018) 
1.2.2 Flavivirus structural Proteins  
Throughout replication, post-translational control of flaviviral structural proteins 
is strictly controlled to regulate efficient virion assembly, secretion and 
infectivity. These proteins and some of their known functions are highlighted in 
Figure 2. 
Capsid protein 
This is a small (approximately 11kDa), highly basic, dimeric cytosolic flaviviral 
protein that is translated at the N-terminus of the polyprotein. It has four 
structurally conserved α-helices and an internal hydrophobic domain that 
presumably interacts with viral membranes while the other side interacts with 
the viral RNA.  Maturation to a soluble protein happens after cleavage from the 
prM signal sequence by the viral encoded NS2B/3 protease (Lindenbach et al., 
2007; Chambers et al., 2003) 
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prM glycoprotein 
This is an approximately 26kDa glycoprotein which is the precursor of the 
membrane protein. It folds quite rapidly and acts as the chaperone of the 
Envelope that is, it assists in the proper folding and secretion of the E protein. 
The N-terminal region of the prM contains one or three N-linked glycosylation 
sites and six conserved cysteine residues all of which are disulfide linked. The 
prM protein has been implicated together with several host factors in the 
flavivivirus life cycle specifically in virus entry, secretion and egress from the cell. 
The prM prevents the Envelope from undergoing rearrangements to a fusogenic 
form during transit in the secretory pathway and the dissociation of its pr 
peptide by furin yields mature virions (Duan et al., 2008; Lindenbach et al., 2007) 
Envelope glycoprotein 
The envelope (E) is a protein of approximately 53kDa and the major surface 
glycoprotein in flaviviruses. It contains 12 conserved cysteins forming disulphide 
bonds. The E protein is the viral hemagglutinin and induces a protective immune 
response and the domain III of this protein is the target of neutralizing 
antibodies. 
Its major function in the flaviviral life cycle is mediating binding of the virus to 
the host receptors and the fusion of the virus onto the host cell membrane.  The 
proper folding and secretion as well as its stability in low pH conditions depend 
on its co-expression with the prM protein (Heinz et al., 1991; Lindenbach et al., 
2007). 
1.2.3 Flavivirus non-structural proteins 
NS1 glycoprotein 
The flavivirus NS1 is a highly conserved glycoprotein, approximately 46 to 55kDa 
depending on its glycosylation status. It is localized in the ER lumen by a signal 
sequence located at the C-terminus of the E protein. This glycoprotein contains 
two or three N-linked glycosylation sites and 12 conserved cysteines that form 
disulfide bonds.  NS1 is thought to be involved in the viral RNA replication. 
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process and the development of disease. NS1 is considered a major viral 
immunogen and found in the blood during early stages of infection as a viral 
marker of infection (Avirutnan et al., 2007; Lindenbach et al., 2007) 
NS2A 
This is an approximately 22kDa, hydrophobic membrane non-structural protein 
that is a product of the processing of the NS2 portion of the flaviviral 
polyprotein. The actual function of NS2A is not entirely known but has been 
suggested to function as a scaffold protein that organizes the replication 
complex (Barrows et al., 2018). It has been suggested that NS2A, alone or in 
complex with NS3, may be involved in genome transport (reviewed by Apte-
Sengupta et al., 2014).  
NS2B 
This is a small membrane associated protein of approximately 14kDa. Its main 
known function is to serve as a cofactor of the viral protease NS3 forming the 
NS2B3 complex. This interaction between the two proteins is absolutely essential 
for optimal protease activity during infection. The cofactor activity of NS2B is 
encoded in a conserved hydrophilic region of 40 residues flanked by hydrophobic 
regions that mediate membrane association, suggesting a possible role of the 
protein in modulation of membrane permeability during infection (Lindenbach et 
al., 2007). NS2B of JEV and DENV have been shown to be associated with lipid 
rafts, a feature which makes them possess membrane-destabilizing properties 
(Cordero et al., 2014; Gopala Reddy et al., 2018). NS2B of JEV has been shown to 
contribute to replication and virion assembly through interaction with NS2A, and 
its transmembrane domains playing a fundamental role in both (Li et al., 2016).  
NS3 
This is a multifunctional, modular protein of approximately 70kDa involved in 
processing of the polyprotein and also in viral RNA replication. NS3 serves as the  
viral protease in the complex NS2B3 by processing the precursor polyprotein and 
therefore in the maturation of viral proteins. However, it harbors an NTPase-
dependent RNA helicase activity in its C-terminus that functions may play a role  
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in genome replication and vRNA synthesis. (Barrows et al., 2018; Li et al., 2014; 
Lindenbach et al., 2007). 
NS4A  
This is a small (≈16kDa), hydrophobic transmembrane protein and one of the 
products of the processing and cleavage of the NS4 portion of the polyprotein 
that yields NS4A and NS4B proteins. The two proteins are linked by a fragment of 
approximately 23 amino acids that form the 2K-linker peptide. NS4A has been 
suggested to be a major driver of ER rearrangements in DENV infection (Miller et 
al., 2007) where the replication factories are assembled, and has a role in 
replication (Lindenbach et al., 1991). NS4A may also help in the organization of 
luminal, transmembrane and cytoplasmic components of replication complexes 
(Barrows et al., 2018) 
NS4B 
This is a transmembrane protein of approximately 27kDa linked to NS4A by the 
2K-linker peptide. The linker specifically leads NS4B into the ER membrane where 
it has been shown to localize at sites of replication as well as in the nucleus 
(Barrows et al., 2018). It has also been shown to interact with NS3 suggesting an 
interaction with the replication complexes, and probably its role in replication. 
NS4B has also been implicated in ER rearrangements (Kaufusi et al., 2014).  
NS5 
 This is the largest (≈ 103kDa), most conserved multifunctional protein that is 
indispensable in viral replication. It contains at its C-terminal the RNA dependent 
RNA polymerase and a methyltransferase at its N-terminus that catalyzes the 
methylation in the genome capping process (Lindenbach et al., 2007). These  
processes are vital for viral genome replication (suggested to occur in complex 
with NS3 by Barrows et al., 2018) as well as viral genome stability and are 
therefore central to the regulation and coupling of RNA synthesis and virion 
morphogenesis (Murray et al., 2008) 
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1.2.4 Virus–induced membrane rearrangements 
A vast majority of viruses from different families have been shown to induce 
extensive membrane rearrangements in the cells they infect and more 
specifically in the endoplasmic reticulum that has been described as a favorite 
niche for most viruses including flaviviruses as the site of replication and 
assembly of viral particles. This is of a particular interest due to different families 
of viruses converging at this particular organelle in the course of infection and 
even incorporating some of the ER intrinsic functions to exert a promotive role in 
almost every step of the life cycle (reviewed by Ravindran et al., 2016).  
The morphological changes are nonetheless quite distinct among DNA and RNA 
viruses as well as among virus families (Fig 4). Studies done in flaviviruses have 
shown dramatic morphology changes of ER membranes in infected cells and 
more importantly the formation of ER-derived invaginations or vesicle packets or 
replication vesicles. This vesiculation of the ER lumen results in the membrane 
sheets become dilated giving rise to swollen ER sacs. The vesicles serve as 
physical support where the replication factories/complexes are anchored for the 
coordinated accumulation of viral and cellular components required for efficient 
replication. Moreover, membranes ensure minimal or no exposure of viral 
nucleic acids to the host immune system by shielding the viral genome from 
cellular pattern-recognition receptors and nucleases (Mackenzie et al., 1999, 
2005; Miorin et al., 2012, 2013; Overby et al., 2010). 
These invaginations of ER membranes retain an open connection to the 
surrounding cytoplasm via a pore that may be involved in the import of host 
factors and nucleotides required for efficient RNA replication and the export of 
the newly synthesized viral genomes (Welsch et al., 2009; Miorin et al., 2013).  
While the actual mechanism of membrane remodeling is unknown, it is thought 
to be a collective output of modulation of host lipid metabolism, influence of 
integral membrane proteins, activity of cytoskeleton components and 
microtubule motors, scaffolding by peripheral and integral membrane proteins 
(McMahon and Gallop, 2005). More importantly is the primal involvement of  
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some viral proteins such as the NS4A and NS4B proteins that have been 
implicated in remodeling of membranes, in DENV and the Kunjin strain of WNV 
infections (Miller et al., 2007; Kaufusi et al., 2014). NS4A and NS4B of DENV 
contain central helices assumed to lie in plane on the ER-luminal membrane 
leaflet, this arrangement is thought to locally increase the membrane surface 
area and induce invaginated vesicles. The oligomerization of NS4A and its 
interaction with NS4B may be the sustenance force to membrane 
rearrangements (Miller et al., 2006, 2007; Stern et al., 2013; Zou et al., 2015).  
However, it has been suggested that additional viral proteins may also play a role 
in the rearrangements that are induced in the morphogenesis of replication 
factories as expression of these proteins alone did not resemble those observed 
in infected cells. One such protein may be NS1 that has been shown to dimerize 
and bind to and remodel membranes in vitro (Akey et al., 2014) and likely 
interacts with the NS4A-NS4B complex (Lindenbach and Rice, 1999; Youn et al., 
2012). In addition, there is a possibility that NS2A might also be involved in the 
induction of flavivirus replication organelles (Chang et al., 1999; Xie et al., 2013; 
Kummerer and Rice, 2002)  
ER invaginations result in vesicle packets, elongated vesicles or tubular structures 
that arise in the ER during DENV and TBEV infection of mammalian cells. The 
abundance of these structures differs between acute and persistent infections, 
with the latter showing more remodeling. These tubules have been suggested to  
be replication factories that are products of anomalous remodeling or represent 
an antiviral cellular defense mechanism restricting infection (Welsch et al., 2009; 
Offerdhl et al., 2012).  
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Figure 4: Different ER morphological changes owed to different families of DNA and RNA 
viruses (Romero-Brey and Bartenschlager, 2016) A) Membrane Inclusions; viral genome 
replication occurs in the cytoplasm in close-association with ER-derived membranes B) ER-
derived invaginations/vesicles or spherules curving towards the ER lumen, what is referred to as 
negative curvature C) Single membrane tubules and Double Membrane Vesicles (DMVs); 
‘exvaginations’ derived outwardly from the ER (positive curvature manner) D) Zippered ER; 
tethered spherules lacking luminal space due to zippering of ER cisternae E) ER-derived 
convoluted membranes, devoid of ribosomes, probably derived from smooth ER membranes 
F)Membranous inclusions; also called viroplasm, of cellular origin and closely surrounded by 
rough ER cisternae, both ER elements and virus particles are in contact with the cytosolic face of 
the plasma membrane that are part of the replication and assembly factory.  
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Figure 5. Representative images of membrane rearrangements induced by different members 
of the family Flaviviridae (Romero-brey and Bartenschlager, 2014). Slices through tomograms of 
cells infected with A) Dengue Virus (DENV); B) West Nile Virus (WNV); C) Tick-borne Encephalitis 
Virus (TBEV); D) Hepatitis C Virus (HCV) showing characteristic virus-induced structures.  
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1.3 Host innate sensing and resistance to flaviviral infection 
1.3.1 Pattern Recognition Receptors  
To establish a potent antiviral state upon infection, target cells possess germ-line 
encoded receptors that recognize distinct signatures from invading pathogens 
known as pathogen-associated molecular patterns (PAMPs), these are conserved 
molecular motifs unique to specific pathogens that are essential for survival, and 
cannot be altered by the pathogen (Nazmi et al., 2014), the PRR-PAMP 
interactions are therefore specific depending on PRR localization and PAMP 
specificity, this is also how the host cells that respond to viral invasion 
differentiate self from “non-self “molecules. 
The identification of these signatures is the core event in the initiation of the 
antiviral signaling cascade which culminates in the production of numerous host 
cell defense molecules including type I and type III interferons that promote an 
antiviral state. These receptors are known as pattern recognition receptors 
(PRRs) and they are located on both the cytoplasm and the cell surface 
(Cumberworth et al., 2017). There are different classes of PRRs but the most 
important as far as flaviviral infections are concerned are the Toll-like receptors 
(TLRs) and the cytoplasmic sensors, retinoid acid- Inducible gene I (RIG-I) like 
receptors (RLRs) and Node-like receptors (NLRs) (Munoz ‐ Jordan and 
Fredericksen, 2010; Takeuchi and Akira, 2010; Suthar et al., 2013).  
1.3.2 Toll-like Receptors 
These are membrane-bound sensors, a family of about 11-12 members that 
detect specific PAMPs. Specific in flavivirus infections, TLR7 and TLR8 identify 
single-stranded RNA (ssRNA) and TLR3 identifies double-stranded RNA (dsRNA) 
produced during viral infection. TLRs sense invading pathogens from both 
outside the cell and in intracellular endosomal compartments, they do so 
through their leucine-rich ectodomains that mediate PAMP recognition. Signaling  
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of all TLRs except TLR3 is mediated by the adaptor protein MyD88 whereas TLR3 
does so through the adaptor protein TIR-domain containing adaptor Inducing 
Interferon β (TRIF) (Kawai and Akira, 2010). The recruitment of these 
intermediate proteins in the course of the cascade leads to activation of the NF-
ĸB, MAPK, ERK, and JNK pathways. TLR3 through TRIF signals through the TRAF3 
and RIP1 signaling pathways to activate the transcription factors IFN‐regulatory 
factor, IRF3, NF-ĸB, and AP-1 to stimulate the IFN-I pathway (Akira et al., 2006).  
1.3.3 RIG-I like receptors 
The RLR family of receptors is made up of three members namely; retinoic acid-
Inducible gene I (RIG-I), melanoma differentiation-associated gene 5 (MDA5) and 
Laboratory of genetics and physiology 2 (LGP2; also known as DHX58). These 
sensors are localized in the cytoplasm and trigger antiviral responses including 
type I interferon (IFN) production and pro-inflammatory signaling following viral 
invasion (reviewed by Pichlmair and Caetano e Sousa, 2007, Rehwinkel and 
Caetano e Sousa, 2010). RIG-I and MDA5 contain a DExD/H box RNA helicase 
domain that hydrolize ATP and binds and possibly unwind the dsRNA in the 
cytoplasm, two caspase-recruitment domains (CARDS) important in signaling and 
carboxyl-terminal repressor domain, which in RIG-I is involved in autoregulation 
(Takeuchi and Akira, 2010; Kato and Fujita, 2015). LGP2 lacks the CARD domains 
and is thought to positively regulate RIG-I and MDA5 (Satoh et al., 2010) 
 
 
 
 
 
 
 
 
Figure 6: RIG-I like receptors RIG-I, MDA5 and LGP2 highlighting the distinctive features of each 
receptor (Kato and Fujita, 2015) 
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1.3.4 RIG-I signaling in flaviviral infection 
The RIG-I cytosolic sensor specifically recognizes ssRNA molecules containing 
free 5’triphosphate (5’ppp) moieties (Cui et al., 2008; Hornung et al., 2006; 
Spiegel et al., 2005; Takahasi et al., 2008), 5’ diphosphate (5’pp) such as those 
found in genomes of some viruses (Pichlmair et al., 2006; Goubau et al., 2014). 
Reportedly, RIG-I has been triggered experimentally by a variety of double-
stranded RNAs (dsRNA) in a length-dependent manner, regardless of the 5’ end 
modifications (Kato et al., 2008).  
In non-infected cells where RIG-I is in a resting state, the CARD domains are 
folded over one another and the Repressor domain is folded over the helicase 
and RNA binding domains (Saito et al., 2007)  
In the course of infection, when the pathogenic signature is recognized, RIG-I 
hydrolyzes ATP and undergoes a conformational change that triggers the 
interaction between the RNA binding domain with the pathogenic RNA. At the 
same time, the CARDs are released for interaction with the adaptor protein 
mitochondrial antiviral signaling (MAVS, also known as IPS-1, VISA, and Cardif), 
located in the mitochondrial-associated membrane (MAM) (Liu et al., 2012). 
MAVS relays the signal to kinases such as TANK-binding kinase 1 (TBK1) and IκB 
kinase (IKKε), which phosphorylate interferon regulatory factors (IRF3, IRF7) and 
nuclear factor-kappa beta (NF-ĸB), to initiate downstream signaling (Hou et al., 
2011) through the translocation to the nucleus to evoke the transcription and 
secretion of Type I interferon, pro-inflammatory cytokines and the establishment 
of an antiviral state within the cell.  
1.3.5 Type I IFN signaling  
The cell intrinsic immunity against cellular insults including viral invasion is a 
conserved entity in nucleated vertebrate cells. It is primarily mediated through a 
signaling cascade that culminates in the production of IFN, virus-induced 
cytokines that are produced by both immune and non-immune cells (de Weerd 
et al., 2013; Chen K. et al., 2017). The first part of this cascade involves the PRR-
PAMP interaction that has been previously explained (Fig. 6A), while the  
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secondary signaling involves the use of the secreted interferon molecules that 
bind to specific receptors on target cells (Fig. 6B).  
The initial production of interferon serves as a “warning/alarm signal” of 
infection but the secondary signaling is what is indispensable in the antiviral 
activity because, IFNs themselves are not antiviral effectors. Rather, they are 
secreted by virally infected cells and act in an autocrine and paracrine 
amplification loop, binding to IFN receptors that signal to induce interferon-
stimulated genes (ISGs) (Caetano Reis e Sousa, 2017). 
 The type one interferons IFNα and IFNβ bind to an ubiquitously expressed 
receptor(s) known as IFNAR1/2 which associates with Janus kinase 1(JAK1) and 
Tyrosine kinase 2(TYK2) kinases which phosphorylate Signal transducer and 
activators of transcription 1 and 2(STAT1 and STAT2) transducer proteins which 
then associate with IRF9 to form the ISGF3 complex that culminates in the 
expression of ISGs, which are the actual antiviral effectors (Stark and Darnell, Jr., 
2012; Ivashkiv and Donlin., 2014). ISGs encode a variety of effector proteins that 
restrict virus propagation by shutting down cell translation, cleaving cellular and 
viral RNAs and blocking virion replication, assembly and/or release (Caetano Reis 
e Sousa, 2017). In addition to antiviral functions, ISGs play a role in the 
modulation of the IFN (Kumar et al., 2003). Several ISGs desensitize cells to IFN 
stimulation, and the ability of the IFN subtypes to signal can be differentially 
affected. 
The type I and type III interferons are both known as the antiviral cytokines but 
the type III interferons signal through a heterodimeric receptor complex IFNLR1 
and is largely restricted to epithelial cells. Even though they bind different 
receptors, both type I and type III interferons regulate similar sets of genes and 
display similar activities (Sommereyns et al., 2008) 
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Figure 7: The IFN pathway of cell intrinsic antiviral Immunity (Caetano Reis e Sousa, 2017). 
Depiction of A) primary and B) secondary type I interferon signaling highlighting the various viral 
PAMPs, their respective PRRs/sensors (e.g. RIGI, MDA5), adaptor proteins (e.g. MAVS) and 
several kinases (e.g. IKKe, TBK1) that phosphorylate regulatory proteins (e.g. IRF3 in the case of 
TBEV), the translocation of which  culminates in the secretion of type I IFN genes that facilitate 
the secondary cascade which involves the IFNAR receptors which bind the IFN molecules, 
followed by the phosphorylation of STAT transducer proteins and nucleus translocation. These 
events culminate in the production of ISGs in the nucleus which are in essence the actual antiviral 
effectors. 
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1.3.5.1 Interferon Stimulated genes 
Following initial discoveries of IFN and its role in cell-intrinsic antiviral immunity, 
the role of ISGs became more apparent with their function as the actual effectors 
of antiviral signaling. Simply defined, an Interferon-Stimulated Gene is any gene 
that is induced during the IFN response. However, some of these genes are 
direct targets of Interferon regulatory factors (IRFs), NF-κB and can thus be 
induced even in the absence of IFN signaling. Additionally, some ISGs exist 
basally but are also IFN- inducible. Factors such as these make the classification 
of ISGs not as simplistic as one would hope (as reviewed by Schoggins, 2019). 
Other ISGs are themselves IFN signaling promoters while others are negative 
regulators targeting PRRs and IRFs. A set of ISGs have also been characterized to 
be pro-viral in some infections (Fig. 8, Chen et al., 2010, Randall et al., 2006) 
Initially, ISGs were identified by the approach of associating their expression with 
virus suppression during infections and functional testing usually followed this. 
Ectopic ISG expression as a gain-of-function approach has also been used.  
However, more recently there has been large-scale screening of ISGs credit to 
development of techniques such as RNA-Seq, CHIP-Seq and Microarray 
technologies as well as the revolutionary gene editing technology, CRISPR-Cas9. 
Some of the mostly characterized antiviral ISGs include those of the Interferon-
induced proteins with tetratricopeptide repeats (IFIT) family, RSAD2 commonly 
known as Viperin, Interferon-inducible transmembrane (IFITM) family and the 
IFI-6-16 family. Some analyses have also been done to identify further the steps 
in the virus life cycle that these ISGs target as well as their mechanism of action 
(as reviewed by Schoggins, 2019) 
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Figure 8: Interferon Stimulated Genes. A simplified depiction of the primary and secondary IFN 
signaling (left panel, Tanguy et al., 2017) and a general categorization of ISGs (right panel). Most 
characterized ISGs are antiviral (red blocked lines), some IRFs are induced independently of IFN 
(Thin blue line), some are themselves IFN signaling promoters (dotted red lines), Others are 
negative regulators targeting PRRs, IRFs (thin, red blocked lines) and some are proviral (green 
lines) (Schoggons’ lab, UT SouthWestern web page)
1.3.6 Virus innate immunity evasion strategies 
To ensure productive, potent infection cycles, viruses have evolved some 
strategies through which they use to evade the host cell innate immunity. They 
do so by hijacking some of the intrinsic cellular functions and using them to their 
advantages and/or using their proteins to inhibit different parts of the innate 
immune signaling cascade thereby defeating the host cell in eliciting an antiviral 
response.   
Flaviviruses are no exception and some members have been shown to 
successfully subvert the innate antiviral signaling and promoting their 
replication. As described earlier, some flaviviruses such as TBEV, DENV and WNV 
replicate in modified ER membranes, which not only serve as replication sites but 
a way to evade PRR-sensing by delaying the host cell immunity (Frederickson and 
Gale, 2006; Mackenzie et al., 1999, 2005; Miorin et al., 2012, 2013) which offers 
a replication advantage during early stages of replication. 
DENV suppresses the IFN signaling cascade by blocking TYK phosphorylation, 
impairing STAT1 phosphorylation, and it targets STAT2 by its NS5 protein for 
proteosomal degradation (Ashour et al., 2009; Mazzon et al., 2009; Green et al., 
2014). NS2A of DENV has also been shown to be important in the RNA synthesis 
and plays a role in the viral evasion of innate immunity by inhibiting the RIG-
I/MAVS signaling by inhibiting TBKI/IRF3 phosphorylation in DENV and HCV  
ISGs 
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infections (Kaukinen et al., 2013; Dalrymple et al., 2015) and the NS1 of WNV has 
been shown to target RIG-I and MDA5 to antagonize IFNβ production (Liu et al., 
2004, 2005; Zhang et al., 2017). Additionally, the NS2B3 complex of DENV2 has 
been shown to target the human cGAS-STING pathway and thus impeding type 1 
interferon signaling (Aguirre et al., 2012, 2017) same as the NS2B3 of WNV 
subtypes NY99 and KUN that prevent the translocation of STAT proteins to the 
nucleus in response to IFN-α treatment (Liu et al., 2005). The roles of NS5 
proteins of different flaviviruses in the antagonism of type I Interferon signaling 
have been reviewed by Best, 2017.  
Even when the primary IFN signaling has been activated, some viruses are able to 
inhibit some ISG effectors from eliciting their antiviral activity for example the 
methylation and capping of WNV RNA, there may be some modulation of the 
activity of the ISG IFIT1 (Daffis et al., 2010; Szretter et al., 2012)  
DENV and JEV block caspase-dependent apoptotic cell death by activating PI3K 
signaling at early stages of infection, which initiates survival signaling to maintain 
the cells in a favorable condition for sustained virus production (Lee et al., 2005) 
1.4 ER stress and the Unfolded protein response (Fig. 9) 
1.4.1 ER stress  
The ER is the designated cellular organelle for protein folding and maturation of 
nascent secretory and transmembrane proteins. To ensure that these functions 
are carried out effectively, the ER lumen maintains a homeostasis in balancing 
the protein load entering the ER and its capacity to handle this load.  
In case of ER perturbations by physiological and pathological insults such as high 
protein demand, viral infections, environmental toxins, inflammatory cytokines, 
and mutant protein expression resulting to an accumulation of misfolded and 
unfolded proteins in the ER lumen, ER stress occurs (Oslowski and Urano, 2011). 
The chronic induction of ER stress by accumulation of misfolded and unfolded 
proteins without the activation of the proceeding remedial pathway is 
characteristic of some disease pathogeneses (as reviewed by Lin et al., 2008) 
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1.4.2 Unfolded Protein response  
The unfolded protein response (Figs. 9, 10) is a cellular response to ER stress, a 
remedial process to restore protein synthesis regulation that is highly conserved 
in vertebrates (Schrodder and Kaufmann, 2005)  
The activation of UPR is mediated by three transmembrane proteins Inositol 
Requiring kinase I (IREI), Activating transcription factor 6 (ATF6) and PKR-like 
endoplasmic reticulum kinase (PERK) that are held in place by the chaperone 
protein BiP/HSPA5/GRP78 in their inactive form. Upon ER perturbation and the 
induction of ER stress, BiP dissociates from these proteins rendering them active 
(Lee, 2005). 
The UPR involves up regulation of chaperone proteins such as BiP, GRP94 and 
PDI to promote protein folding, translational attenuation to reduce the load of 
proteins within the ER, preventing further accumulation of misfolded proteins, 
and up-regulation of ER-associated protein degradation (ERAD) as well as 
autophagy to promote degradation of misfolded proteins (Zhu and Lee, 2015). In 
circumstances of prolonged ER stress, however, the UPR becomes pro-apoptotic 
and triggers cell death (Perri et al., 2015) 
The unfolded protein response as the name suggests is almost always assumed 
to be in response to the presence of unfolded proteins that create ER stress.  
However, it has been shown in yeast to also be due to changes in the ER lipid 
composition, in essence a more specific stress on the membranes with little or 
no involvement of unfolded proteins. This was performed in IRE1 mutants that 
were deficient in their ability to bind unfolded proteins. Other forms of stress 
stimuli culminating in membrane and/or lipid composition changes may be 
detected by the UPR sensors (in this case IRE1) in a different manner (Promlek et 
al., 2011). The mechanism that IRE1 employs has been further expounded on 
that the sensing mechanism relies on a juxta-membrane amphipathic helix that 
causes local membrane compression and acyl chain disordering. This way, the 
amphipathic helix can sense aberrant physical membrane properties. IRE1 is 
therefore able to combine both stress due to unfolded proteins as well as lipid  
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bilayer stress (Halbleib et al., 2017). In mouse cells, both IRE1α and PERK can be 
activated by luminal-independent signals in cells with enhanced lipid saturation, 
this is to say lipid perturbation may also be such a stimulus that can invoke UPR 
in the absence of unfolded proteins Volmer et al., 2013.  
The plasticity nature of the ER allows for its dilation in conditions of stress. This is 
true for both ER stress due to external stimuli but also due to different cellular 
requirements such as B-cell differentiation that is typically accompanied by 
expansion of the ER (van Anken et al., 2003).  
ER expansion/dilation can be measured by estimating the amount of 
phospholipid biosynthesis that occurs during UPR in response to ER stress. This is 
done by labelling cells with fluorescent dyes that can bind to lipid droplets and 
then analysed by flow cytometry and/or fluorescent microscopy (Yu et al., 2006) 
 More elaborate morphological changes occur during viral infection as a result of 
emergence of replication vesicles where viruses exploit the ER during the 
different steps of their life cycle. The morphology of these vesicles is due to 
changes in ER shaping proteins such as a family of Rab GTPases (Mateus et al., 
2018) and tubule formation proteins such as the Reticulon family of proteins. ER 
membrane rearrangements appear to be specific among viruses as discussed in 
section 1.2.4 and summarised in Figure 4. ER dilation and/or remodelling in this 
context, i.e. during virus infection can be visualized by electron microscopy which 
has been extensively used to study replication vesicles in multiple viruses 
(Oslowski et al., 2011, Romero-Brey and Bartenschlager,2016). 
1.4.2.1 ATF6 
ATF6 is a type II transmembrane protein with two isoforms ATF6α and ATF6β. 
ATF6 has its carboxyl terminus on the luminal side and a basic leucine zipper 
(bZIP) transcription factor in its amino terminus (Yoshida et al., 1998; Haze et al., 
1999). In response to ER stress, ATF6 is trafficked to the Golgi apparatus, where 
it undergoes regulated intramembrane proteolysis by sequential cleavage by site 
1 and site 2 proteases (S1P and S2P, respectively) (Hetz et al., 2011). This 
releases a 50kDa fragment that translocates to the nucleus and there it functions  
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as a transcriptional activator that upregulates many UPR genes related to protein 
folding. (Haze et al., 1999; Lee et al., 2002; Yamamoto et al., 2007). 
1.4.2.2 IREI 
IREI is an approximately 110kDa type I transmembrane protein with a serine-
threonine kinase domain and a RNase domain. There exist two isoforms of the 
protein: IREIα and IREIβ but the earlier is the ubiquitously expressed form. Upon 
activation, IRE I oligomerizes and subsequently allowing transphosphorylation of 
juxtaposed kinase domains. This activates the RNase domain, which cleaves XBP1 
mRNA (encoding ‘X-box-binding protein 1’, a transcription factor of the bZIP 
family) at two discrete stem-loop structures through an unusual cytoplasmic 
splicing reaction. The resulting fragments are ligated by an RNA ligase, yielding 
the active transcription factor XBP1s (Cox et al., 1996; Yoshida et al., 2001). 
XBP1s translocates to the nucleus and induces the expression of chaperones, 
molecules involved in lipid biosynthesis and ERAD. 
IREI is the most conserved arm of the UPR and appears to respond to a vast 
majority of UPR inducers, possibly an evolutionary consequence as a sole ER 
stress sensor (DuRose et al., 2006) 
1.4.2.3 PERK 
PERK is an ER-localized type I transmembrane protein. When UPR is activated, 
oligomerization of PERK in the ER membranes occurs inducing its trans-
autophosphorylation and kinase domain activation (He, 2006; Kim et al., 2008). 
PERK further phosphorylates the a subunit of eukaryotic translation initiation 
factor 2(eIF2α) on Ser51, resulting in the shutdown of mRNA translation and 
therefore reducing the load of newly synthesized proteins entering the ER lumen 
(Hetz et al.,2006). An exceptional case to this general response is that certain 
mRNAs gain a selective advantage for translation under conditions in which 
eIF2α is phosphorylated (Lu et al., 2004), most common is the transcription 
factor ATF4 which activates the transcription of prosurvival genes as well as pro 
apoptotic genes such as CHOP. Additionally, ATF4 is a co-factor to GADD34,  
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whose role is to dephosphorylate eIF2α reversing protein synthesis attenuation 
with a negative feedback mechanism (Novoa et al. 2001). 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 9: Unfolded Protein Response (Janssens et al., 2014) 
1.4.3 Chemical vs Physiological Induction of UPR (Fig. 10) 
There are several pharmaceutical UPR inducers with different modes of action 
available and routinely used in cell culture systems to induce ER stress and 
activate the UPR. These include Tunicamycin, Thapsigargin, Brefeldin A, 
dithiothreitol (DTT), and MG132. Oxidative cellular stress associated with 
changes in the translocon complex results to a global protein translation halt, a 
typical event in UPR induction through the PERK pathway. Compounds such as 
puromycin and aminoacid analogues lead to the aggregation of misfolded 
polypeptudes in the ER, eliciting stress and ultimately induce UPR (Hightower, 
1980., Hammadi et al., 2013, Druelle et al., 2016, Schwenzer et al., 2019). 
There are also some physiological UPR induction methods that have been 
reported to induce mild ER stress such as the deprivation of glucose to cells. The 
concentrations used and duration of induction are predetermined based on cell 
systems used and generally, the kind of output expected from an experiment 
(Oslowski and Urano, 2011; Bergman et al., 2018). ER stress and UPR induction  
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by either chemical or physiological inducers differs from cell to cell and activate 
the UPR in a specific manner. However, while these agents act in different ways, 
they all converge in their ability to induce an accumulation of unfolded 
glycoproteins in the ER, activating ER stress and ultimately UPR.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10: ER stress and Unfolded Protein Response induction (So, 2018) 
Other methods of physiological induction of ER stress and UPR involve different 
strategies that amount to the accumulation of misfolded or unfolded proteins in 
the ER and by doing so achieving a more organelle-specific induction (protein 
overload which in theory is confined to the lumen of the ER) as opposed to 
general perturbation of cellular homeostasis. The strategies investigated in this 
study are reported herein. 
siRNA interference of BiP 
Apart from being a major chaperone in the ER, BiP binds the three UPR 
transducers in non-stressed cells and dissociates from them under conditions of 
ER stress and in doing so, activates the UPR. In line with this and evidence from  
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previous reports in HEK293 and HeLa cells (Suzuki et al., 2007), the depletion of 
BiP by siRNA transient knockdown has been shown to induce ER stress and 
activating UPR. 
Overexpression of BiP ATPase mutants 
BiP (also known as HSPA5, GRP78) is a chaperone protein in the ER with 
numerous functions including folding of nascent proteins, targeting misfolded 
proteins for degradation (ERAD) and regulating the UPR. BiP has two major 
domains; the N-terminal domain contains an ATP catalytic site and the C-
terminal domain contains the substrate-binding site. The two domains 
communicate by binding and releasing ATP and unfolded peptides respectively 
to regulate activity and most of the activities of BiP are dependent on its ATPase 
activity for proper function (Mayer et al., 2005) 
BiP ATPase mutants have amino acid substitutions within the nuclear binding 
domain, which renders the protein unable to carry out its activities. Some of 
these mutants include G227D, a non-ATP binding mutant and T37G, an ATP-
conformational change induction mutant (Hendershot et al., 1996). The 
overexpression of the ATPase mutants will impair the folding capacity of the ER, 
thereby inducing ER stress and UPR.  
Overexpression of ectopic proteins such as α1-antitrypsin mutants 
The alpha 1 anti-trypsin (α1AT) is a member of the serpin family of protease 
inhibitors that inhibit proteases and protect tissues from damage (Fregonese et 
al., 2008).  
α1AT mutants may induce either an overload of proteins in the ER (polymer 
aggregation) or accumulation of misfolded proteins. A common and widely 
studied mutant of α1AT is the null Hong Kong (NHK) mutant, a truncated variant 
that does not fold properly. While the wild type (α1AT) is completely secreted, 
only a fraction of the NHK mutant can be secreted thus inducing ER stress and 
activate the UPR (Ordóñez, et al.,2013; Ferris et al., 2013).  
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1.4.3.1 Cancer as a physiological ER stress inducer 
As shown in figure 10, physiological stressors include cancers and viral infections.  
In general, the elicitation of UPR induction relies on the sustenance of the 
inducing stimuli in exerting ER stress. Cancer-induced ER stress is implicated in 
the initiation of transformation, unrestricted cell division, invasion and spread of 
tumorigenic cells. In most cancers, ER stress is accompanied by hypoxia and 
nutrient deprivation especially in the early stages of tumorigenesis (Chipurupalli 
et al., 2019; Madden et al., 2019). Transformed cells take advantage of the pro-
survival mechanisms of UPR to sustain growth and proliferation of tumorigenic 
cells and meeting the vast protein folding demands accompanied by the 
progression of cancer. However, unlike in viral infections (next section, 1.4.3.2) 
where ER stress can be a direct result of accumulation of viral proteins as well as 
those of the host, the process of tumorigenesis ultimately results to a protein 
load, almost always solely belonging to the host cells. And depending on the 
circumstances and cell’s condition, UPR activation may also help the resistance 
to treatment and production of clones less sensitive to chemotherapy. In most 
cases, UPR activation is a vital step for oncogenic transformation, as UPR 
signaling molecules interact with well-established oncogene and tumor 
suppressor gene networks to modulate their function during cancer 
development (Walczak et al., 2019). 
1.4.3.2 Virus-induced ER stress and UPR 
As previously discussed, virus replication and/or assembly of newly synthesized 
viral progeny for most flaviviruses occurs in the ER. This implies a large 
accumulation of viral proteins within the ER resulting into a protein overload in 
the ER lumen during infection, the essence of ER stress and subsequently UPR 
activation. Several studies have suggested a connection between UPR activation 
and either the process of viral replication (herpes simplex virus (HSV) 1, JEV, and 
HCV (Su et al., 2002; Cheng et al., 2005; Tardif et al., 2005) or the production of a 
specific viral protein in the ER (Zhang and Wang, 2012). For example, the ectopic  
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expression of the E2 protein, but not E1, core and NS3 proteins of Hepatitis C 
virus (HCV), has been shown to activate the expression of BiP (Liberman et 
al., 1999). HCV replicons expressing only non-structural proteins are also capable 
of stimulating BiP expression (Tardif et al., 2002). 
Like innate signaling, viruses have evolved to use the UPR signaling to their 
advantage throughout the life cycle as reviewed by Ambrose and Mackenzie, 
2013b and Green et al., 2013, suggesting in some instances a pro-viral function. 
This selective manipulation of the UPR is also different when the infection is 
acute or chronic.  
Any viral infection whether acute or chronic is an arms race between the host 
cell and the virus with the host attempting to eradicate the virus and the virus 
trying to take advantage of the various responses including the UPR, 
manipulating them to its advantage.  
While pro-survival is a common goal in any virus infection, as far as the UPR is 
concerned, the major difference is that chronic infections are skewed in that the 
virus targets some parts of the stress response with an aim of promoting 
persistence and/or latency. Indeed, such is the case in Hepatitis C which activates 
all three arms of the UPR but after this initial upregulation and peaking, there 
follows only milder stress that is long-lived. This is made possible by increased 
eIF2α phosphorylation alleviating the protein translation halt thus supporting the 
HCV chronic infection and later with diminished CHOP levels avoiding immediate 
cell death (Mercuiol et al., 2011; reviewed by Chan et al., 2014). HCMV is the 
largest human herpesvirus encoding at least 200 proteins. Its replication is 
relatively slow and due to its size, it is understandably stressful for the cell and 
particularly the ER to endure the slow replication. For this reason, HCMV has 
evolved to mitigate this by an upregulation of BiP throughout its cycle. BiP helps 
to control the prevailing UPR due to infection by protein folding, and has been 
shown to play some roles in virus assembly and egress (Buchkovich et al., 2010). 
In other cases, viruses may decide to only utilize certain arms of UPR and inhibit 
others such as HSV that strongly activates GADD34 to relieve the protein  
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translation inhibition while WNV activates only ATF6 and XBP1 but not PERK so 
as to bypass the translation halt. Different viruses and how they may manipulate 
the UPR to their advantage have been reviewed by Dash et al., 2016. 
1.4.4 The UPR and antiviral immunity 
The role of UPR in the remedial of ER stress has increasingly been associated 
with modulation of immunity and inflammation activities revealing more about 
functions other than ER stress management. The UPR has also now been 
recognized for its role in immune cell differentiation and function, and in 
regulating immune and inflammatory responses, including those associated with 
infections, tumors and autoimmune responses (reviewed by Grootjans et al., 
2016).  
When cells undergoing an acute UPR upon treatment with Tharpsigargin were 
treated/transfected with TLR and MDA5 agonists, there was an augmentation in 
TLR-induced cytokines and IFNβ production, a log-fold or more over the PRR 
agonist alone. In dendritic cells, this synergistic effect was shown to be 
dependent on the transcription of XBP1 (Smith et al., 2008; Hu et al., 2011) 
This synergistic effect was not only observed upon pre-treatment with 
pharmacologic agents, cells expressing the misfolding α1AT mutant responded to 
LPS with greater cytokine production (Caroll et al., 2010). This synergistic effect 
has been observed in multiple culture cell types, human and mouse 
macrophages as well as dendritic cells as shown. 
There is also evidence that UPR sensing of Influenza hemaglutinin (HA) triggers a 
direct anti-IAV response by targeting HA degradation via the ER associated 
degradation pathway (ERAD). The host cells detect HA as a misfolded or 
“nonself” protein and ER mannosidases target HA to ERAD for degradation and 
limit IAV replication (Frabutt et al., 2018). 
There is increasing data showing that the UPR may be a danger signal that 
synergizes with PRR-sensing to elicit an antiviral state or may do so via activation 
of intrinsic pathways such as ERAD to limit infection (as reviewed by Janssens et 
al., 2014; So, 2018). 
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1.4.5 ER stress, UPR and interplay with autophagy 
While the last resort for cells undergoing prolonged ER stress is cell death, 
autophagy can help cells to cope with mild ER stress by its contribution to 
elimination of misfolded and unfolded proteins suggesting a certain amount of 
cross-talk between them. Additionally, certain stimuli such as nutrient starvation 
that have been documented to induce mild ER stress can also induce autophagy. 
The interplay between the two has mostly been described in some specific 
disease conditions such as kidney and neurodegenerative diseases. Some 
autophagy genes have been shown to be activated after activation of ATF4, a 
PERK-mediated factor during the unfolded protein response. Both IRE1 and ATF6 
have also at one time or another been implicated in the modulation of the 
cellular autophagy process (Cai et al., 2016; Cybulsky, 2017; Hosoi et al., 2017).  
More generally though, in conditions where this interplay exists, UPR elicited by 
ER stress stimulates autophagy and the three UPR sensors may distinctively 
modulate certain points of the autophagy process. PERK- dependent eIF2α 
phosphorylation has been shown to contribute in the activation of autophagy in 
response to the accumulation of unfolded proteins. Activation of IRE1 has also 
been shown to regulate autophagy when cells were treated with ER stress 
inducers TM or TG or proteasome inhibitors led to an IRE1-dependent activation 
of autophagy which relies on the interaction  of IRE1 with TRAF2 and JNK 
activation. These and other distinct ways on how individual arms of UPR 
converge into the autophagy pathway are comprehensively reviewed by 
Verfaillie et al., 2009; Senft & Ronai, 2015; Kabir et al., 2018.  
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1.5 Aim of thesis 
My thesis stemmed from previous observations pertaining to the role of UPR in 
the elicitation of a robust antiviral state during flavivirus infections. 
• As a prerequisite, my first task was to analyze the effects of UPR inducers TM 
and TG on cell growth and viability in our current experimental settings 
• Additional to this, my central objective was rooted into the search for 
alternative UPR inducers, an attempt to induce UPR in a more specific 
manner targeting the endoplasmic reticulum, which is the site of replication 
for many flaviviruses but the center for protein folding and therefore central 
in ER stress and UPR signaling. 
• Upon success, to evaluate this alternative of UPR induction in the context of 
antiviral signaling during TBEV infection as I also analyzed the same with the 
inducer Tunicamycin. 
 
2.MATERIALS AND METHODS 
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2.1 Materials 
2.1.1 Cells 
 
Human cells 
• U2OS: Human osteosarcoma cell line (ECACC No. 92022711)  
• Vero: African green monkey kidney (ECACC No. 84113001) 
• HEK 293T: Human embryonic kidney cell line with the SV40 T-antigen 
 
Bacteria cells 
• MAX Efficiency DH10B Competent Cells (Invitrogen – cat. no. 18297-010). 
Genotype: F- mcrA Δ (mrr-hsdRMS-mcrBC) φ80lacZΔM15 ΔlacX74 recA1 
endA1 araD139 Δ (ara, leu)7697 galU galK λ- rpsL nupG 
• MAX Efficiency DH5α Competent Cells (Invitrogen – cat. no. 18258012 
Genotype: F- Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 hsdR17 (rk-, 
mk+) phoA supE44 λ-thi-1 gyrA96 relA1	
 
2.1.2 Media 
Human cells 
• Cells were grown in Dulbecco’s modified Eagle’s medium (DMEM) Gibco – 
cat. no. 31885-023 (Life Technologies) supplemented with 10% fetal bovine 
serum (FBS; REF 10270-106, EU approved, Brazil, Life Technologies), 0.1 U/ml 
penicillin, and 0.1μg/ml streptomycin at 37°C in 5% CO2.  
• Reduced serum medium (Opti-MEM) was used during transfection. The 
media and serum were purchased from Gibco – cat. no. 31985-070. 
• Cell freezing medium was made by 90% FBS and 10% DMSO (Sigma-Aldrich 
cat.no. 472301-500ML) for long-term storage.  
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Bacteria cells  
• Luria-Bertani (LB) Medium: 10g bacto-trypton, 5g bacto-yeast extract, 10g 
NaCl per 1 liter medium. Ampicillin or Kanamycin was added at a 
concentration of 100μg/ml and 50μg/ml respectively.  
For hardening 1.5% agar-agar was added to the liquid medium. 
• SOC Medium: Super Optimal Broth (SOB) medium (20g bactotrypton, 5g 
bacto-yeast extract, 0.5g NaCl per 1L medium) was enriched with 20mM 
glucose. 
2.1.3 Antibodies 
2.1.3.1 Primary Antibodies  
Antibody Species  Dilution Source/Reference 
4G2 Mouse       1:20000 WB Kindly provided by Dr. Vivian Huerta 
Center for Genetic Engineering and 
Biotechnology (CIGB), Cuba 
FLAG®M2 Mouse • 1: 1000 WB 
• 1: 5000 FC 
Sigma-Aldrich - cat. no. F1804 
SV5 Mouse • 1: 10000 WB 
• 1: 5000 FC 
Kindly provided by Oscar Burrone; 
Laboratory of Molecular Immunology 
(ICGEB) 
BiP Mouse       1: 1000 WB • BD Biosciences - cat. no. 610979 
• Kindly provided by Oscar Burrone; 
Laboratory of Molecular 
Immunology (ICGEB)  
Table 1: Primary antibodies used in this study (WB= Western Blot, FC=Flow Cytometry) 
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2.1.3.2 Secondary antibodies 
Antibody Species Dilution Source/Reference 
Anti-mouse AlexaFluor 488 Donkey 1:500 FC Molecular probes 
(Invitrogen cat.no. 
A32723) 
Anti-mouse/HRP Rabbit 1:10000 WB DakoCytomation  
(cat. no. P0447) 
Anti-rabbit/HRP Goat 1:10000 WB DakoCytomation 
(cat. no. P0449) 
Human β-Actin Peroxidase Mouse  1: 50000 WB Sigma-Aldrich  
(cat.no. A3854) 
Table 2: Secondary antibodies used in this study (WB= Western Blot, FC=Flow 
Cytometry) 
	
2.1.4 siRNAs 
Pools of small interfering RNAs (siRNAs) against BiP (ON-TARGET plus 
SMARTpool, 5nmol siRNA cat.no. L-008198-00-0005) and control pool ON-
TARGETplus Non-targeting Pool, 5nmol siRNA cat.no. D001810-10-05) were 
purchased from Dharmacon and used according to manufacturer’s instructions. 
2.1.5 Vectors 
Plasmid analysis was performed on SerialCloner version 2-6-1 
 
Plasmid Characteristics Reference/Source 
pcDNA3 BIP (grp78) 
human 
 
• Encodes Wild type 
BiP/grp78 
• AMPR 
• Kindly provided by 
Dr.Oscar Burrone; 
Laboratory of 
Molecular 
Immunology (ICGEB) 
• Sasset et al., 2015 
 
pcDNA3 BIP (grp78) 
human G227D 
 
• Encodes a non-ATP 
binding BiP mutant 
• AMPR 
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pcDNA3 BIP (grp78) 
human T47G 
 
• Encodes an ATP-
conformational change 
induction BiP mutant 
• AMPR 
•  
pcDNA3-AAT-SV5-BAP 
 
• Encodes an SV5-
tagged wild type α1AT 
• AMPR 
pcDNA3-AAT-D318-
SV5-BAP 
 
• Encodes an SV5-
tagged null Hong Kong 
mutant of α1AT 
• AMPR 
pEGFP-C1 
 
• Encodes the GFP 
mutant 1 variant  
• KANAR 
• BD Biosciences 
Clontech  
cat. no. 6084-1  
• Cormack et al., 1996 
pcDNA 3.1(+) 
 
• Empty vector 
• AMPR 
Invitrogen-cat.no. V79020 
pl.18 TBE Hy C 3xFlag 
 
• Encodes Flag-tagged 
TBE Capsid protein 
• AMPR 
• Kindly provided by Dr. 
Anna K. Överby; 
MIMS, Umeå 
Universitet, Sweden 
• Överby et al., 2010 
• Tarpey and 
Greenwood, 2001. 
 
 
 
 
 
 
 
pl.18 TBE Hy prM 
3xFlag 
 
• Encodes Flag-tagged 
TBE pre-Membrane 
protein 
• AMPR 
pl.18 TBE Hy E 3xFlag 
 
• Encodes Flag-tagged 
TBE E protein 
• AMPR 
pl.18 TBE Hy NS1 
3xFlag 
 
• Encodes Flag-tagged 
TBE non-structural 
protein 1 
• AMPR 
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pl.18 TBE Hy NS2A 
3xFlag 
 
• Encodes Flag-tagged 
TBE non-structural 
protein 2A 
• AMPR 
 
pl.18 TBE Hy NS2B 
3xFlag 
 
• Encodes Flag-tagged 
TBE non-structural 
protein 2B 
• AMPR 
pl.18 TBE Hy NS3 
3xFlag 
 
• Encodes Flag-tagged 
TBE non-structural 
protein 3 
• AMPR 
pl.18 TBE Hy NS4A 
3xFlag 
 
• Encodes Flag-tagged 
TBE non-structural 
protein 4A 
• AMPR 
pl.18 TBE Hy NS4B 
3xFlag 
 
• Encodes Flag-tagged 
TBE non-structural 
protein 4B 
• AMPR 
pl.18 TBE Hy NS5 
3xFlag 
 
• Encodes Flag-tagged 
TBE non-structural 
protein 5 
• AMPR 
pGL3 IFN-β Luc 
 
• Encodes the Firefly 
Luciferase gene under 
control of the IFN-β 
promoter  
• AMPR 
• Lin et al., 2000 
pEF-BOS-FLAG-RIG-IN 
 
• Encodes Flag-tagged 
RIGI (active domain 
only, not full-length) 
• AMPR 
• Kindly provided by Dr. 
Takashi Fujita (Kyoto 
University) 
• Yoneyama et al., 2004  
Table 3: Plasmids used in this study	
2.1.6 Primers  
Primers were designed using the NCBI Primer Designing Tool 
(http://www.ncbi.nlm.nih.gov/tools/primer-blast/), following optimal 
parameters and selecting only the primers spanning exon–exon junctions to 
minimize genomic DNA amplification. All primers were synthesized by and 
purchase from Sigma-Aldrich or Intergrated DNA Technologies (IDT).  
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Oligonucleotide name  Sequence: 5’ to 3’ 
β-Actin Fw  CAT GTG CAA GGC CGG CTT CG 
β-Actin Rv GAA GGT GTG GTG CCA GAT TT 
BiP Fw  CCC GAG AAC ACG GTC TTT GA 
BiP Rv  TCA ACC ACC TTG AAC GGC AA 
CHOP Fw TAA AGA TGA GCG GGT GGC AG 
CHOP Rv CTG CCA TCT CTG CAG TTG GA 
DNAJC3 Fw  CGT TTG CGT TCA CAA GCA CT 
DNAJC3 Rv  CCC GAA CTT CAC TGA GGG AC 
EDEM1 Fw  AGG ACC AAG GGG GAA AGT CT 
EDEM1 Rv  GTA CAC GAT TGC AGT TGG AGC 
GADD34 Fw  CCC AGA AAC CCC TAC TCA TGA T 
GADD34 Rv CTC GGA GAA GCG CAC CTT T 
GAPDH Fw CAT GAG AAG TAT GAC AAC AGC 
GAPDH Rv AGT CCT TCC ACG ATA CCA AAG 
IFI44 Fw AGA CGA ATG CTA TGG GCT GC 
IFI44 Rv CCT CCC TTA GAT TCC CTA TTT GCT C 
IFI44L Fw TCA AAG CCG GGT CAT GAA TG  
IFI44L Rv CCT TCA TGG GGT CCA GTT CC  
IFIH1 Fw GAT TCA GGC ACC ATG GGA AGT  
IFIH1 Rv AGG CCT GAG CTG GAG TTC TG  
IFIT1 Fw GAA ATA TGA ATG AAG CCC TGG A 
IFIT1 Rv GAC CTT GTC TCA CAG AGT TCT CAA 
IFNβ Fw  AGG ACA GGA TGA ACT TTG AC 
IFNβ Rv  TGA TAG ACA TTA GCC AGG AG 
OASL Fw TAC CAG CAG TAT GTG AAA GCC A 
OASL Rv GGT GAA GCC TTC GTC CAA CA 
TBEV 5’ NCR Fw GCG TTT GCT TCG GA 
TBEV 5’ NCR Rv CTC TTT CGA CAC TCG TCG AGG 
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Viperin Fw CCC CAA CCA GCG TCA ACT AT  
Viperin Rv TTG ATC TTC TCC ATA CCA GCT TCC 
XBP1s Fw CTG AGT CCG CAG CAG GTG 
XBP1s Rv GGC TGG TAA GGA ACT GGG TC 
XBP1u Fw AGC CAA GGG GAA TGA AGT GAG G 
Table 4: Sequences of primers used in this study	
2.1.7 Solutions  and Buffers 
• 1X PBS (1 litre) 
In 800 ml of distilled water, the following were added; 8 g of NaCl, 0.2 g of 
KCl, 1.44 g of Na2HPO4, 0.24 g of KH2PO4. pH adjusted to 7.4 and distilled 
water was added to bring solution to volume of 1 liter. 
• 2X HBS buffer 
42mM HEPES (Sigma-Aldrich cat. no. H4034-100G), 274mM NaCl, 1.5mM 
Na2HPO4.12H2O, 15mM D-glucose and pH adjusted to 7. 
• 5X TBE (1 litre) 
54g Tris base (Invitrogen cat.no. 15504-020), 27.5g Boric acid (Sigma-Aldrich 
cat.no. 31146), 20ml 0.5M EDTA (Sigma-Aldrich cat.no. E5134-1KG) and 
distilled water to final volume of 1 litre. 
• 3.7% Paraformaldehyde (PFA) 
5ml of 37% PFA: 1.85g of PFA powder, reagent grade crystalline (Sigma-
Aldrich cat. no. P6148-500G) dissolved in 5ml of distilled water, 10μl 10M 
KOH. 37% PFA was diluted in 2x PHEM buffer (18.14g PIPES (ChemCruz 
cat.no. sc-216099); 6.5g HEPES; 3.8g EGTA; 0.99g MgSO4; pH adjusted to 7 
with 10M KOH) to produce 3.7% PFA. 
• 6% carboxymethyl cellulose (CMC) 
500 ml; 30g CMC powder (Sigma-Aldrich cat. no. C5013-500G) dissolved in 
500ml PBS  
• 1% Crystal violet solution 
1L; 10g Crystal violet powder (Sigma- Aldrich cat.no. C6158-50G), 200ml PBS 
and 800ml Methanol (Sigma-Aldrich cat.no. 32213-2.5L-M) 
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• SDS electrophoresis buffer (10X) 
30.2g Tris, 188g Glycine (Sigma-Aldrich 33226-1KG), 50ml 10% SDS (Sigma-
Aldrich L5750-500G), add water to 1 litre 
• 10X Transfer Buffer (1 litre)  
30.3g Tris, 144g Glycine, add water to 1 liter 
 
§ 1X Transfer buffer (1 litre): 100ml 10X Transfer Buffer, 200ml 
Methanol and 700ml water. 
• 10X TBS (1 litre) 
60g Tris, 2g KCl, 80g NaCl, pH adjusted to 8.5 with 37% HCl, add water to 1L 
§ 1X TBS-T (1 litre): 100ml 10X TBS, 900 ml water, 1ml Tween-20 
(Sigma-Aldrich P2287) 
• 100mM PMSF 
17.4 mg of PMSF (Sigma-Aldrich cat.no. P7626) in 1ml of isopropanol (Riedel-
de Haën cat.no. 603-117-00-0) 
• EDTA and EGTA solutions  
EDTA (Sigma-Aldrich cat.no. E5134-1KG) and EGTA (Sigma-Aldrich cat.no. 
E3889-100G) dissolved in H20. 
• Nonidet-P40 (NP-40) 
20mM Tris HCl pH 8, 137 mM NaCl, 10% glycerol (Sigma-Aldrich cat.no. 
49770-1L), 1% nonidet P-40 (Calbiochem cat.no. 492015) and 2 mM EDTA 	
2.1.8 Size Markers and Dyes 
• PageRuler Plus Prestained Protein Ladder, Thermo Scientific cat.no. 
26619 
• 100bp DNA Ladder (5u/μl), Promega cat.no. G2101 
• 1kb DNA ladder (100μg/ml), Promega cat.no. G571A 
• DNA markers supplied with Blue/Orange 6X Loading dye, Promega 
cat.no. G190A 
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2.2 Methods 
2.2.1 Cell culture 
Cells were grown at 37°C, 5% CO2 in DMEM complete medium. Cell passaging 
was done by treatment with 0.05% Trypsin – 0.02 % EDTA and seeded at 
appropriate dilutions.  
Cell culture was done in aseptic conditions, cells were routinely screened for 
Mycoplasma contamination and new cell stocks were revived at regular intervals. 
2.2.2 Whole genomeTranscription analysis  
 U2OS cells were seeded into 10cm plates, the next day, they were infected with 
TBEV at a MOI = 1, after one hour of infection with serum free medium, this 
medium was replaced with complete growth medium alone for the cells with just 
infection or complete medium plus TM in sterile treatment and infection and 
treatment with TM. RNA samples were then collected at 0, 10 and 24 hours post 
infection in EuroGOLD TriFast lysis buffer (EuroClone EMR 507100) and total RNA 
was extracted. Quality of extracted RNA was checked by spectrophotometric 
analysis (260/280>1.8) and Agilent bioanalyzer (RNA integrity number, RIN≥8). 
Our collaborator Danilo Licastro, CBM-Trieste performed further analyses and I 
report herein the protocol that was followed.  
Briefly, cDNA libraries of polyA-containing mRNA molecules were prepared using 
Illumina TruSeq standard protocol. Libraries were pooled and sequenced on two 
different Illumina Platforms. The first run was performed on Hiseq2000 4-plex 
run single reads, 50 bp reads while the second run was performed on HiscanSQ 
8-plex run pair-end reads, 2x100bp reads. All data were subjected to quality 
control using FastQC software.  
Briefly, bioconductor packages DESeq2 version 1.4.5. and EdgeR version 3.6.2 in 
the framework of R software version 3.1.0 were used to perform differential 
gene expression analysis of RNA-seq data. Both packages are based on the 
negative binomial distribution (NB) to model the gene reads counts and 
shrinkage estimator to estimate the per-gene NB dispersion parameters.  
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Specifically, rounded gene counts were used as input and the per-gene NB 
dispersion parameter was estimated using the function DESeq for DESeq2 while, 
for edgeR the function calcNormFactors with the default parameters was used. 
To detect outlier data after normalization, R packages 
Array Quality Metrix were used and before testing differential gene expression 
all genes with normalized counts below 14 were eliminated to improve testing 
power while maintaining type I error rates. Estimated p-values for each gene 
were adjusted using the Benjamini-Hochberg method. Genes with adjusted 
P<0.05 and absolute Logarithmic base 2-fold change > 1 were selected. 
2.2.3 Ingenuity Pathway Analysis  
Significantly changed genes (up-regulated, down-regulated, or both) were 
analyzed by Danilo Licastro using online bioinformatics tool Ingenuity Pathway 
Analysis (Qiagen). Direct relationships were included with experimentally 
observed or highly predicted confidence from human species. Canonical 
pathways, diseases and disorders, and molecular and cellular functions were 
analyzed. 
 2.2.4 Plasmid transformation 
DH10β or DH5α competent cells were used for transformation of all plasmids in 
this study. Cells were incubated with the plasmids on ice for 30 min. They were 
then heat-shocked at 42°C for 40 seconds, left on ice for 2 minutes before 
addition of SOC medium. Cells were then incubated at 37°C for 1.5 hours before 
they were plated onto LB agar with the required antibiotic. They were grown 
overnight at 37°C.On the next day, selected colonies were picked and inoculated 
into 5 ml of LB medium containing the required antibiotic. 
2.2.5 Plasmid DNA extraction 
After approximately 12-15 hours, plasmid DNA was extracted using NucleoSpin 
Plasmid (Macherey-Nagel cat.no.1801/003) for minipreps and/or NucleoBond 
Xtra Midi (Macherey-Nagel cat. no. 1803/009) for midipreps. Extracted DNA was 
authenticated by restriction endonuclease digestion and sequencing. Restriction  
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endonucleases and their specific buffers were purchased from New England 
Biolabs (NEB). 
2.2.6 Plasmid transfection 
• Lipofectamine LTX transfection 
Plasmids were transfected into U2OS cells using Lipofectamine™ LTX Reagent 
with PLUS™ Reagent (Invitrogen cat.no. 15338-100) according to a standard, 
optimized protocol. Transfection was done using reduced serum medium (Opti-
MEM) and further grown in DMEM supplemented with 10% FBS. 
 
• Calcium Phosphate transfection 
Transfections for luciferase reporter assay were performed in HEK293T cells 
using a standard, optimized protocol. Transfection was done in DMEM 
supplemented with 10% FBS and further incubated at 37°C, 5% CO2 until sample 
collection. 
2.2.7 siRNA transfection of BiP  
U2OS cells were reverse transfected that is cells were seeded onto the 
transfection mix. siRNAs used were at a concentration of 20nM and transfection 
was performed using Lipofectamine RNAiMAX transfection Reagent (Invitrogen 
cat.no. 13778-075) according to the manufacturer’s instructions. Cells were then 
incubated at 37°C, 5% CO2 in DMEM complete medium for 48 hours before 
infection with TBEV. 
2.2.8 Flow Cytometry  
Efficiency of transfection was checked for all experiments involving plasmid 
transfection. Cell monolayers were treated with 0.05 % Trypsin – 0.02 % EDTA to 
prepare single cells suspensions. Cells were then washed twice with PBS. For 
EGFP control, cells resuspended with 500μl PBS and immediately analyzed by 
flow cytometry.  
Anti-SV5 and FLAG assays involved the fixation of cells with 3.7% 
paraformaldehyde (PFA) for 15 minutes at room temperature, followed by  
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centrifugation at 1000 rpm for 5 minutes followed by two washes, the first with a 
buffer made up of a 0.1% Tween 20 in PBS solution and the second with 1X PBS, 
at 1000 rpm for 5 minutes per wash. 
Permeabilization was done by 0.05% Saponin-0.1% BSA solution incubated for 15 
minutes at room temperature followed by two washes as described above for 
fixation. 
Primary and secondary antibodies (anti-SV5/anti-FLAG or Alexa Fluor 488) were 
diluted in 0.1% Tween 20 in PBS solution. Anti-SV5 was used at 1:5000, anti-FLAG 
at 1:50 and Alexa Fluor 488 at 1:500 dilutions. Cells were incubated with primary 
antibodies for 30 minutes at room temperature followed by two washes. The 
same conditions were used for secondary incubation but without exposure to 
light followed by two washes as described previously. 
Cells were finally resuspended in 500μl PBS and analyzed on a FACS Calibur 
machine (Becton Dickinson) and the Cell Quest Pro software. 
Appropriate controls were employed every time including untreated cells and 
those only treated with the secondary antibodies as well as empty vector 
controls for normalization.  
2.2.9 Infection and Tunicamycin treatment of Cells  
• Virus stocks  
Neudoerfl strain of TBEV was used for all experiments reported herein. 
Viral stocks were prepared by infection of Vero cells at multiplicity of 
infection of 0.1. After observation of cytopathic effects (CPE), the 
supernatant was collected, clarified by centrifugation, supplemented with 
20 % FBS, and stored in aliquots at -80°C. Viral titres were determined by 
using a plaque-forming assay. 
When performing infection experiments, U2OS cells were seeded in a 12 well 
plate at an appropriate confluence. 24 hours later, cells were infected at 
multiplicity of infection (MOI=1) by adding 400μl of virus stock properly diluted 
in serum-free medium.  
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After 1 hour incubation at 37°C with 5%, CO2, the inoculum was replaced with 
DMEM supplemented with 4 % decomplemented FBS except for the condition of 
Tunicamycin treatment where at medium change, the medium contained 1μg/ml 
of Tunicamycin (Sigma-Aldrich cat. no. T7765-1MG) or 0.5mM of Tharpsigargin 
(Sigma-Aldrich cat. no. T9033-1MG). T0 (0 h.p.i) is the time after this first hour of 
incubation with the virus and subsequent time points are counted from this 
initial point. Control cells, mock infected and cells untreated with inducer(s) were 
also used.  
2.2.10 Cell Lysis 
Depending on the type of analysis to be performed, cells were lysed in one of the 
following lysis buffers: 
• Laemmli Buffer (50 mM Tris-Cl pH 6.8, 2% SDS, 10% glycerol, 100 mM DTT, 
0.1% bromophenol blue-Bio-Rad cat.no. 161-0404) 
• RIPA buffer (50 mM Tris-Cl pH 7.5, 150 mM NaCl, 1% NP-40, 0.1% SDS, 1mM 
EDTA, 1mM EGTA, 1mM PMSF, 0.5% Sodium deoxycholate (Sigma-Aldrich 
cat.no. D6750-100G) and Proteinase Inhibitors (Roche - 11836170001) and 
Phosphatase Inhibitors: Sodium Fluoride (Riedel-deHaën 30105) and Sodium 
Orthovanadate (Sigma-Aldrich S6508-10G 028K0117) 
• 5X Reporter Lysis Buffer (RLB) Promega cat.no. E397A, diluted to 1X for 
harvest of luciferase samples 
2.2.11 Bradford Assay 
Quantification of cell lysates was performed by Bradford assay. Briefly, 250μl of 
1X Bio-Rad Protein Assay Dye reagent (Bio-Rad Laboratories GmbH cat.no.500-
0006) was pipetted into clear 96-well plate according to the number of samples 
in duplicates. Known concentrations of BSA diluted from a 10mg/ml 100X stock 
(Promega cat.no. R396D 24122438) ranging from 0.5 to 4μg/μl were then added 
into respective wells, likely 2μl of cell lysates were added into respective wells. 
1X Bio-Rad Protein Assay Dye reagent was used as blank. All samples were  
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carefully mixed by pipetting up and down and immediately read at wavelength 
595 nm on a Wallac Envision 2104 Multilabel Plate Reader (Perkin Elmer). The 
known concentrations were used to plot a standard curve that was subsequently 
used to calculate the concentrations of unknown samples.  
2.2.12 SDS PAGE 
Whole cell lysates were resolved by SDS-PAGE at appropriate acrylamide 
percentages. The lysates were boiled at 95°C for 10 minutes, centrifuged for 1 
minute at RT at 1000 rpm, and subsequently loaded into the acrylamide gel. Gels 
were run in SDS electrophoresis buffer, initially at 80V into the stacking gel and  
later at 140V into the running gel. 
2.2.13 Western blot 
Nitrocellulose membrane (GE Healthcare – cat.no. 10600015) was used at 
transfer at 350mA for 1.5 hours. Blocking was done for 1 hour in 5% milk/BSA 
depending on protein to be checked followed by incubation with appropriate 
primary antibodies diluted in 5% milk/BSA for 1 hour at room temperature or 4°C 
overnight (O/N) depending on antibody. Secondary antibodies conjugated with 
HRP (DakoCytomation – cat.no. P0447/8) were diluted in 5% milk/BSA depending 
on protein to be checked and blots were incubated for 1 hour at room 
temperature. Washes were done with TBS 0.5% Tween-20 solution.  Blots were 
developed using Immobilon®Crescendo Western HRP Substrate (Millipore – cat. 
no. WBLUR0500) according to manufacturer’s instructions. 
2.2.14 Luciferase Assay 
The luciferase assay to assess the IFNβ promoter activity resulting from co-
transfection of NS2B and/or RIGI-N with IFNβ was performed using 250μl of 1X 
RLB per well of a 12-well plate. Cells were then scraped and harvested followed 
by freeze and thaw cycles in dry ice and room temperature respectively to 
facilitate cell lysis.  A centrifugation step was then carried out at 12000g for 30 
seconds and supernatants were collected and stored at -20°C until analysis.  
For analysis, 50μl of Luciferase substrate was pipetted into white 96-well-plates  
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in duplicate followed by addition of 25μl of respective samples, 1X RLB buffer 
was used as a blank. Samples were mixed well and measurements of IFNβ-
luciferase activity in cell lysates were performed using the Wallac Envision 2104 
Multilabel Plate Reader (Perkin Elmer). All measurements were normalized to 
individual protein concentrations that were quantified with the Bradford assay 
method as described previously. 
2.2.15 RNA extraction, cDNA synthesis and qRT-PCR 
Samples for quantitative reverse transcription PCR (qRT-PCR) were lysed and 
collected with EuroGOLD TriFast buffer. Total cellular RNA was extracted 
according to the manufacturer’s protocol. RNA samples were resuspended in 
autoclaved water and treated with DNase I recombinant, RNase Free Kit (Roche 
cat. no. 04716728001) before being quantified by a Thermo Scientific™ 
NanoDrop 2000.  
500 ng of total RNA was then reverse transcribed using dNTPs (Promega cat. no. 
U144B), 150ng/μl random primers (Invitrogen cat.no. P/N 58875), 5X First Strand 
Buffer, 0.1M DTT and M-MLV Reverse Transcriptase (Invitrogen cat.no. 28025-
013) RNase Inhibitor (Promega N2518), in a reaction mix.  
Quantification of mRNA was obtained by real-time PCR using the 2X qPCR 
SyGreen Mix Separate ROX cat.no. PB20.14-05 qPCR kit (PCR BIOSYSTEMS) on a 
CFX96 Bio-Rad thermocycler. The different primers used are listed in Table 4. 
Analysis of relative gene expression was performed using the 2−ΔΔCT method of 
normalization (Livak and Schmittgen, 2001) with β-Actin as the housekeeping 
gene of choice. 
2.2.16 XBP1 splicing RT PCR 
cDNA was synthesized from 500ng total RNA samples as described previously. 
Subsequently, RT PCR was performed using the GoTaq®G2 Flexi DNA Polymerase 
kit (Promega cat.no. M7805). The amplicon spanning XBP1 splicing site was 
amplified using the Xbp1u Fw and Xbp1s Rv primers and GAPDH as control (Table 
4) under the following conditions: 95 °C for 5 minutes, 95 °C 30 seconds, 60 °C 30 
seconds, 72 °C  
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30 seconds for 35 cycles and 72°C 2 minutes. PCR products were run on a  
2% Agarose gel for 45 minutes at 80V. Gel preparation: UltraPure™ Agarose 
powder (Invitrogen cat.no. 16500-500) melted in 0.5X TBE buffer and mixed with 
Ethidium Bromide-250ng/ml. Agarose gels were visualized using the UVIdoc HD2 
gel documentation system (UVITEC Cambridge) 
2.2.17 Plaque assay 
Viral yields quantification was done by plaque assay using Vero cells. Cells were 
seeded in 24-well plates in on the first day. On the next day when the monolayer 
was formed, cells were infected in duplicate with a 10-fold serial dilution of TBEV 
in a total volume of 200μl of serum-free medium. After 1 hour incubation at 
37°C, 5% CO2, the inoculum was removed and a 1ml overlay containing 6% CMC 
and normal medium (DMEM supplemented with 4 % decomplemented FBS) at a 
ratio 1:1 was added. The cells were incubated for 5 days at 37°C, 5% CO2. 
To develop, the medium/CMC solution was removed, cells were then fixed with 
3.7% PFA for 20 minutes at room temperature. Cells were stained with 1% crystal 
violet solution and incubated for 20 minutes at room temperature. After 
incubation, the staining solution was removed and cells were washed with water 
until the plaques were visible enough for counting. 
Viral yields were determined by counting the average number of plaques formed 
in the duplicate wells and multiplied by the dilution factor. 
2.3 Figures and Statistical Analysis  
At least two independent experiments in triplicate repeats were conducted 
unless indicated otherwise. GraphPad Prism 7 for Mac OS X was used to generate 
all figures and perform all statistical analyses. Mean values are shown with 
standard deviation and p-values, measured with an unpaired two-tailed t-test or 
one-way ANOVA as indicated in figure legends. Significant p-values are denoted 
by asterisks (p≤0.05 = *; significant, p≤0.01=**; highly significant and p≤0.001 = 
***; extremely significant). Where asterisks are missing the differences are not 
significant. 
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3.1 The UPR primes an earlier and more robust antiviral signaling   
Our laboratory has extensively studied the UPR and its interplay with innate 
immunity. When I started my doctoral degree, I was involved in a team effort to 
make sense of a series of observations pointing at a role of the UPR in concert 
with the innate signaling system in priming the host cell in its response to 
flavivirus infection, boosting its antiviral activity.  
The key observation was that in the course of TBEV infection, the UPR pathway is 
active as early as 8 hours after infection, while the interferon response occurred 
at later time points (starting from 16 hours). When this pathway is pre-activated 
by Tunicamycin, a commonly used UPR inducer that inhibits protein N-linked 
glycosylation, there is an up regulation of IFNβ (Fig. 11B) as well as virus 
inhibition not just for TBEV (Fig. 11A) but also for several other members of the 
Flaviviridae family such as WNV, DENV and ZIKV. Similar effects were observed 
also with another drug Thapsigargin (TG) that inhibits ER Ca2+-dependent ATPase 
and depletes the ER Ca2+ supply (Fig. 11A, C). 
The results of this work have been recently published and the paper is appended 
to this thesis for ease of reference. Although I have been involved in replicating 
several experiments pertaining to this work, which helped me develop essential 
skills in molecular biology and virology, I am reporting in this thesis only those 
where I have been the principal responsible scientist, as well as follow up 
unpublished experiments. 
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Figure 11: UPR inhibits TBEV and up regulates IFNβ: TBEV infection (white bars) and TBEV 
infection and treatment with either TM (grey bars) or TG (black bars) at 24 h.p.i A) TBEV yields in 
PFU/ml as quantified by plaque assay, B-C) IFNβ mRNA quantification by qRT-PCR on TM or TG 
treatments. Results presented as normalized to β-Actin and relative fold increase over T0 time 
point (**p≤0.01, ***p≤0.001 unpaired, student’s t-test) – data obtained from Carletti and Zakaria 
et al., 2019 
3.1.1 UPR inducers Tunicamycin and Tharpsigargin are not cytotoxic but 
cytostatic 
Historically, most UPR studies employ the use of pharmaceutical inducers such as 
Tunicamycin (TM) and Tharpsigargin (TG); our studies on UPR are no different as 
can be seen from figure 10. However, majority of the said chemical inducers may 
act pleiotropically and this may probably have some effects to the cellular 
activities. This certainly depends on the concentrations and/or cell systems used.  
To exclude any toxic effect of the UPR-inducing drugs and to ensure the 
reliability of our data obtained from routine use of the UPR inducers TM and TG, 
I took the initiative to test these two inducers’ effects on cell growth and/or 
viability. The protocol implemented to perform this experiment imitated an 
infection experiment except the infection itself. 
Briefly, as indicated in figure 12A, I seeded 50000 U2OS cells per well in a 12-well 
plate format; the next day, I removed the medium and added serum free 
medium for 1 hour like I would do in an infection experiment. After 1 hour, I 
added fresh complete medium to the mock control cells (U2OS) or complete  
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medium containing 1μg/ml TM or 0.5μM TG, concentrations that we routinely 
use for our experiments. After the one hour, I collected the T0 RNA samples and 
counted cells with Trypan blue. More samples were collected at time points 4, 8, 
24 and 32 hours after treatment (subsequently referred to as T4, T8, T24, T32, T 
= time point). The time point beyond 24 hours was purposefully chosen to cover 
the infection cycle of flaviviruses that take longer than 24 hours.  
When taking the cell counts, I took note of all dead and alive cells at the 
indicated time points to determine the percentage viability (Fig. 12C) and RNA 
was used in a qRT-PCR to check the expression of housekeeping genes β-Actin 
and GAPDH that we commonly use in our qRT-PCR analyses. This was to test 
whether the TM and TG had any effect on that as well.  
As can be observed in figure 12B, the Mock control cells grew exponentially 
throughout the time course while cells treated with both TM and TG appeared to 
be somewhat stagnant between 0 and 8 hours but then grew consistently 
between 8 and 24 hours and even more between 24 and 32 even though at a 
slightly slower rate than the control cells. The restored growth pattern especially 
at 24 hours and forward is not unexpected and is quite consistent with the 
declining exposure of the drugs on cells as the time course progresses.  
qRT-PCR of β-Actin and GAPDH revealed that the Cq values of both housekeeping 
genes ranged between 15 and 17 in all conditions except at 24 hours in the TG 
treatment where it rose to 19. When compared by a t-test, there was no 
significant difference between the average Cq values of both genes at all time 
points (Fig. 12D). 
 These results indicate that both TM and TG at the concentrations used in our 
experiments have a rather cytostatic effect on cell growth, since there was no 
substantial cell death as can be seen in the percentage viability plot (Fig. 12C). 
This suggests that at the concentrations used, TM and TG have a minimal 
detrimental effect if any on U2OS cells in the course of our experiments.  
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Figure 12: TM/TG cytotoxicity assay over the course of 32 hours A) schematic representation of 
experimental procedure B) Average cell counts of mock cells and cells under TM or TG treatment 
C) Percentage viability of cells counted in B, D) Average absolute Cq values of β-Actin (black bars) 
and GAPDH (grey bars) of mock cells and cells treated with TM or TG. 
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3.1.2 An antiviral signature characterizes the early UPR-driven antiviral 
response during TBEV infection  
During TBEV infection, the kinetics of IFNβ activation are concomitant with IRF3 
phosphorylation and its translocation to the nucleus in conditions of infection 
with a pre-activated UPR. While involving IRF3, this antiviral activity is 
independent of the canonical interferon signaling and IRF3 has additionally been 
implicated in other flaviviruses namely, DENV2, WNV and ZIKV. Specific to TBEV, 
the IRE1 arm of the UPR confers this antiviral activity and other arms may be 
valid for different viruses. These observations suggest a vital link between UPR 
and the cellular innate signaling and the two acting in concert to elicit a robust 
antiviral state against flavivirus infection. (Carletti and Zakaria et al., 2019).  
The observation of UPR antiviral signaling being independent of the canonical 
IFN signaling and dependent on IRF3 instigated a whole genome transcriptome 
analysis (in collaboration with Dr. Danilo Licastro,CBM-Trieste,Italy) to better 
characterize this antiviral activity owed to UPR during TBEV infection.  
The analysis was carried out on three groups of U2OS cells subjected to different 
treatments; first group was of cells on sterile Tunicamycin treatment (1μg/ml), 
second, cells only infected with TBEV and the third group, cells treated with TM 
and infected with TBEV, MOI = 1. All cells were subjected to their individual 
treatments for 8 hours, after which RNA samples were collected (Fig. 13A). RNA 
was extracted and checked for integrity and quality prior to analysis. 
Three replicates for each condition were subjected to high-throughput RNA-
Sequencing analysis and the data were analyzed using bioinformatics tools by Dr. 
Licastro as described in the Materials and Methods chapter. 
An analysis with Ingenuity Pathway Analysis (IPA) revealed UPR as the most 
enriched pathway in the condition of sterile TM treatment as expected, and no 
pathway was particularly enriched in the condition of TBEV infection alone. 
However, in the condition of both TM treatment and TBEV infection, IPA 
revealed the following as the most up regulated pathways; “Activation of IRF by  
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cytosolic PRR”, “Interferon signalling”, “Role of PRRs in recognition of bacterial 
and viruses” and “Role of RIG-I like receptors in antiviral innate immunity”.  
Furthermore, a differential analysis was performed between the group of sterile 
TM treatment (UPR activation alone) and that of treatment and TBEV infection. 
This analysis revealed a set of 39 genes that were differentially modulated 
between the two conditions. Of these genes, 21 representing 53.8% of all genes 
were ISGs and were up regulated in the condition of both TBEV infection and TM 
treatment as observed in the heat map. (Fig. 13B – C).  
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Figure 13:Whole genome transcriptome analysis 
of U2OS cells under sterile TM treatment, TBEV 
infection and TBEV infection and TM treatment 
conditions A) Schematic diagram for RNA-Seq 
sample collection B) Heat map showing 
differentially modulated genes between 
conditions of sterile TM treatment (TM) and TBEV 
infection and treatment with TM (TBEV+TM) 
performed in U2OS cells (upregulated genes in 
red, downregulated genes in blue, following the 
indicated scale) C) Pie chart showing percentages 
of the 39 differentially modulated genes shown in 
heat map. Genes with adjusted p<0.05 and 
absolute logarithmic base two-fold change>1 
were selected. Data were analysed with the IPA 
software as described in Materials and Methods.  
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I followed up on the transcriptomic data (Figs. 13B, C) and validated the 
differential analysis findings by qRT-PCR. I followed the same experimental 
scheme as shown in figure 14A except that I collected samples at 10 hours and 
24 hours after TBEV infection. As opposed to the 8-hour time point used in the 
transcriptomic analysis (Fig. 13), the 10-hour time point was used to reiterate the 
time points in a previous differential analysis (not reported herein) that showed 
UPR as a relevant up regulated response in the window of time between 10 and 
24 hours. 10 hours when TBEV replication is already active but no induction of 
IFNβ, a delay strategy employed by TBEV and at 24 hours when both IFNβ 
induction and TBEV multiplication are detectable (Carletti and Zakaria et al., 
2019). Clearly the events in the transcriptomic analysis (Fig. 13) at 8 hours are 
still relevant at 10 hours (Fig. 14) and this difference in time points is not at all 
consequential to the outcomes. From the 21 ISGs identified in the differential 
analysis (Fig. 13B), I chose the top 4 most up regulated genes namely: OASL, 
IFI44, IFI44L and IFIH1. Additionally, I tested for the induction of IFIT1 and 
Viperin, which are known broad antiviral ISGs that have been previously 
described as having antiviral activity towards several flaviviruses (Wacher et al., 
2007; Vonderstein et al., 2017; Lindqvist et al., 2018) 
The qRT-PCR data reiterated the differential analysis in that there was a 
significant induction of the analyzed ISGs in the condition of TBEV infection and 
treatment with TM (Fig. 14A-F) with OASL, IFIH1, IFIT1 and Viperin showing 
significant induction at both time points while IFI44 and IFI44L showing 
significant induction at the 10 hour and 24 hour time points, respectively. These 
results reinforced the results from the transcriptomic analysis on the 
fundamental role of ISGs in the UPR-driven antiviral state during TBEV infection. 
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Figure 14: Validation of selected ISGs from differential analysis (Fig.13); cells were subjected to 
conditions of sterile TM treatment (white bars), TBEV infection (grey bars) and TBEV infection 
and TM treatment (black bars) at 10 and 24 hours post infection. qRT-PCR quantification of A) 
OASL B) IFIH1 C) IFI44 D) IFI44L E) IFIT1 and F) Viperin. Results presented as normalized to β-Actin 
and fold change over the T0 time point (*p≤0.05, **p≤0.01, ***p≤0.001 unpaired, student’s t-
test). 
3.2 Alternative methods of UPR induction 
The results shown previously in figure 12 were certainly convincing enough of 
the minimal effects of TM and TG in our experimental settings. Nevertheless, I 
sought out to find alternatives that could possibly replace the use of 
pharmaceutical UPR inducers as employed from figures 11 to 14 and possibly 
recapitulate the observations in our previous results (Carletti and Zakaria et al., 
2019). This was meant to reinforce our previous observations by using a different 
way of UPR induction but also to attempt that induction in a more organelle-
specific manner that is by targeting the ER as opposed to what may be described 
as widespread/pleiotropic targeting by chemical inducers.  
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For these reasons, several approaches to induce ER stress and eventually UPR 
were explored and are reported herein. 
3.2.1 UPR induction by depletion of the chaperone protein BiP 
GRP78 alias BiP is the main ER chaperone that sequesters the three 
transmembrane proteins; ATF6, IRE1 and PERK that are principle effectors of 
UPR and dissociates from them under conditions of ER stress. Taking advantage 
of this fact, I attempted to deplete BiP and in essence on one hand, making it 
absent to handle the folding of the incoming protein load but also the elicitation 
of ER stress due to impairment and/or lack of the sequestration of the UPR 
effector proteins that is carried out by BiP. 
To this end, I reverse-transfected U2OS cells with 20mM of small interfering RNA 
targeting BiP or the control siRNA following the manufacturer’s protocol. After 
48 hours of incubation at 37°C, I infected the cells with TBEV, MOI = 1, and 
collected supernatants, cell lysates and RNA samples at time points 0, 8 and 24 
hours after infection. 
The depletion of BiP by siRNA was confirmed by an anti-BiP western blot (Fig. 
15A) and in this condition, while not as potent as TM, qRT-PCR analysis showed 
substantive induction of the spliced form of XBP1 and IFNβ mRNAs at all time 
points with increasing levels throughout the time course as compared to the 
siCTRL (Fig. 15B, C), suggestive of an active UPR and innate signaling just as has 
been observed in our previous results (Carletti and Zakaria et al., 2019).  
XBP1s mRNA is considered the classical marker of an active IRE1, the most 
conserved arm of the UPR (Zhang et al., 2016) and is typically used as the 
readout for an active UPR.  
It is important to note that this induction of XBP1s and IFNβ mRNAs at the T0 
time point is purely a consequence of the depletion of BiP and not infection as 
this time point is only after 1 hour of infection. 
However contrary to our previous observations, there was no difference in viral 
yields between the condition of BiP depletion and siCTRL, in fact, the yields were  
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similar in both conditions and both more than those observed in the condition of 
treatment with TM (Fig. 15D). A possible reason could be that as efficient as the 
knockdown was to induce XBP1s and IFNβ mRNA, this may not be efficient 
enough to reflect in virus inhibition. 
 
 
 
             
 
              
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15: UPR induction by depletion of BiP followed by TBEV infection: siCTRL and TBEV 
infection (black bars), siBiP and TBEV infection (grey bars), TBEV infection and treatment with TM 
(white bars), A) Anti-BiP western blot confirming depletion of BiP by siRNA B) qRT-PCR 
quantification of spliced XBP1 and C) IFNβ mRNAs after BiP depletion and TBEV infection (results 
presented as normalized to β-Actin and fold change over siCTRL) D) Quantification of TBEV viral 
yields in PFU/ml as quantified by plaque assay after BiP depletion and TBEV infection (**p≤0.01, 
***p≤0.001 unpaired, student’s t-test) 
3.2.2 Expression of BiP mutants does not induce UPR 
Next I attempted inducing UPR by ectopic expression of two mutants of the 
chaperone protein BiP; namely G227D and T37G. These mutants are impaired in 
their ATPase-dependent nuclear binding domains; the ATPase activity is pivotal 
in the ability of BiP to fold nascent proteins that come into the ER.  It was  
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therefore, plausible to reason that the mutants’ impairment in protein folding 
would lead to an increase in the de novo protein load, thereby overloading the 
ER and in so doing, enable the induction of ER stress and then UPR. 
To address this, I seeded 50000 U2OS cells per well of a 12-well plate, the next 
day I transfected the cells with 500ng of respective plasmids. Transfection was 
performed using Lipofectamine LTX following astandard, optimized protocol and 
after approximately 5 hours of incubation at 37°C, the transfection mix was 
replaced with complete medium and incubated further overnight. The positive 
control cells were treated with TM for the same amount of time as the 
transfected cells. After approximately 16 hours, I collected cell extracts and RNA 
samples. Cell lysates were analyzed for expression by western blot with anti-BiP 
antibody, while RNA was used for cDNA synthesis and analyzed by qRT-PCR for 
quantification of the spliced form of XBP1.  
Efficiency of transfection was measured by flow cytometry and ranged between 
50% and 65% for all constructs. Expression of the BiP proteins was confirmed by 
an anti-BiP western blot (Fig. 16A) and the difference in expression between 
ectopic expression and baseline levels as observed in the 3 controls (cells 
transfected with an empty vector, cells treated with Lipofectamine LTX alone and 
untreated U2OS cells) is quite obvious.  
However, the mutants G227D and T37G were not able to sufficiently induce UPR 
as observed in the quantitative measurement of the mRNA of the spliced form of 
XBP1s showing minimal levels such as those seen in the BiP WT (Fig. 16B). This 
was also true for the induction of IFNβ mRNA (Fig. 16C). The minimal induction 
of IFNβ in the TM condition is consistent with what is expected in the condition 
of sterile treatment with TM i.e in the absence of infection (Fig. 14) 
One possible reason for this result could be compensation in protein folding by 
the endogenous BiP in the case of BiP mutants’ expression. A possibly more 
feasible approach could be to perform a co-transfection of the mutants and wild 
type BiP with a secretory protein and in this case, the protein folding ability or 
lack thereof in the case of the mutants would be more comparable. 
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Figure 16: UPR induction by Expression of BiP mutants A) Anti-BiP western blot showing 
expression of BiP WT, G227D and T37G mutants B) Quantification of XBP1s mRNA after 16 hours 
transfection by qRT-PCR, reults presented as normalized to β-Actin and fold change over BiP WT 
(L.LTX=Lipofectamine LTX) 
3.2.3 UPR induction by expression of Null Hong Kong  
The next attempt involved yet again an ectopic expression approach only this 
time, it was of a verified UPR inducer; null-hong kong (NHK) a truncated mutant 
of the alpha 1 anti-trypsin (α1AT) that does not fold properly and therefore 
overloads the ER and induces the UPR (Ordóñez et al., 2013). While α1AT is 
completely secreted, NHK is considered secretion-incompetent and only a 
portion of it can be secreted. 
To do this, I performed the experiment following the same scheme as in figure 
16, this time transfecting SV5-tagged NHK or the control α1AT plasmids using 
Lipofectamine LTX and like before TM treatment was included as a positive 
control for UPR induction. Whole cell lysates were collected and tested for 
protein expression and secretion by anti-SV5 western blot while RNA was used 
for cDNA synthesis. Successively; these samples were analyzed for their ability to  
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induce UPR by quantification of the mRNA of XBP1s by qRT-PCR. An anti-SV5 
flow cytometry analysis was also performed to check for transfection efficiency 
using a standardized protocol and results normalized to an empty vector. The 
transfection efficiencies ranged between 60% and 64% for all constructs.  
Expression and secretion of both proteins was confirmed by an anti-SV5 western 
blot and a difference in size that reflects the difference in amino acids is clearly 
visible between α1AT and NHK, and only a small portion of NHK was secreted as 
is expected (Fig. 17A). And as previously documented in the literature, NHK 
seemed to significantly induce the spliced form of XBP1 (Fig. 17B) but not IFNβ 
mRNA (Fig. 17C).  
While NHK could not induce significant IFNβ levels, its ability to significantly 
induce XBP1s prompted the next step which was a follow-up with TBEV infection 
to check whether in the condition of NHK expression and infection, there would 
be a UPR-driven inhibition of the virus as was observed in the case of infection 
and treatment with TM.  
The same experimental scheme as in figures 17A-C was followed but with an 
additional step of infection on the following day. Whole cell lysates, 
supernatants and RNA were then collected at T0, T4, T12 and T24 time points 
and analyzed by anti-SV5 WB and qRT-PCR.  
Upon infection, there was modest induction of IFNβ as a consequence of NHK 
transfection at T4 and T8, this induction was however not significant. Moreover, 
an up-regulation in the induction was observed at T24 most likely due to 
increasing virus multiplication and this was the case in all treatments (Fig. 17D). 
While this result was not supportive of our hypothetical model, I noticed a trend 
of modest inhibition of TBEV replication in the condition of expression of NHK 
from T12 (Fig. 17E), which like the induction of IFNβ mRNA in figure 17D was not 
significant.  
Moreover, I was not able to reproduce this phenotype of the inhibition in TBEV 
replication in subsequent experiments even with further optimization of the 
experimental scheme in attempt to improve the efficiency of transfection even 
more than it was initially.  
		 69	
Results 
 
 
 
 
 
 
 
 
 
 
 
  
  
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
Figure 17: UPR induction by expression of Null Hong Kong A) Anti-SV5 western blot showing 
expression and secretion of α1AT and NHK B) qRT-PCR quantification of spliced XBP1 C) IFNβ and 
D) TBEV mRNAs in the conditions of infection with α1AT, NHK transfection or treatment with TM 
as positive control. Results presented as normalized to β-Actin and fold change over α1AT (A, B) 
or T0 time point (D, E). C.E=cell extract, sup= supernatant (**p≤0.01, student’s t-test) 
 
 
 
 
 
 
 
 α1
AT
 su
p 
NH
K s
up
 
NH
K C
.E 
 
SV5 
 
 
 
 
β-Actin 
 
B C 
T4 T8 T1
2
T2
4
0
10
20
50
150
250
350
h.p.i
IF
N
β 
m
R
N
A
 (r
el
at
iv
e 
fo
ld
 in
cr
ea
se
)
α1
AT
 C.
E 
D E 
T4 T8 T1
2
T2
4
0
200
400
600
15000
65000
115000
α1AT
NHK
TBEV+TM
TBEV
h.p.i
TB
EV
 m
R
N
A
 (r
el
at
iv
e 
fo
ld
 in
cr
ea
se
)
A 
α1
AT NH
K TM
0
5
10
15
16 h.p.t
XB
P1
s 
m
R
N
A
 (r
el
at
iv
e 
fo
ld
 in
cr
ea
se
)
**
α1
AT NH
K TM
0
1
2
3
4
5
16 h.p.t
IF
N
β
 m
R
N
A
 (r
el
at
iv
e 
fo
ld
 in
cr
ea
se
)
		 70	
Results 
 
3.2.4 A screen of TBE viral proteins identifies some potent UPR inducers 
Since previous attempts to induce UPR by inducing protein overload were 
deemed unsuccessful, I decided to shift my focus to the physiological route of 
UPR induction following TBE virus infection. From our previous observations and 
the literature, the process of infection occurs with an unscheduled overload of 
the viral proteins on the host cell’s machinery and more specifically the ER, thus 
inducing stress and UPR. In TBEV infection, kinetics of UPR induction range 
between 8 and 12 hours after infection (Carletti and Zakaria et al., 2019).  
By this logic, it was plausible to reason that ectopic expression of TBE viral 
proteins would also be able to induce the response like it happens during 
infection. An additional advantage to this approach was the possibility of 
identifying the viral component(s) that could be responsible for induction of UPR 
in the course of TBEV infection.  
To accomplish this, I began by a screen of all TBE viral proteins to identify 
candidates for ER stress and UPR induction. All 3 structural and 7 non-structural 
proteins, a kind gift from Dr. Anna K. Överby; have been individually cloned in a 
high expression plasmid pl.18 and contain a FLAG tag (Table 3) at her lab in 
MIMS, Umeå Universitet, Sweden.  
To do this, I performed the experiment following the same scheme as in the 
figures 15 and 16, this time transfecting each construct as well as an empty 
vector. Additionally, untreated cells (U2OS) and cells treated with TM were 
included as controls. After approximately 16 hours of transfection, whole cell 
lysates were collected for anti-FLAG WB and RNA samples for qRT-PCR analysis. 
Cells treated with TM for the same amount of time were used as a positive 
control. Assessment for transfection efficiency was performed by an anti-FLAG 
flow cytometry analysis and normalized to an empty vector. Transfection 
efficiencies ranged from 50% to 95% for all constructs. 
All 10 viral proteins were expressed successfully as confirmed by an anti-FLAG 
western blot (Fig. 18A) and from the analysis of qRT-PCR data on the 
quantification of the spliced form of XBP1, 3 out of the 10 viral proteins E, NS1  
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and NS2B showed a significant induction either comparable or more than the 
positive control, TM (Fig. 18B). This was also true for the induction of IFNβ for 
the three proteins in addition to the prM protein (Fig. 18C). These results imply 
that the ectopic transfection of TBE viral proteins is a viable method of inducing 
UPR in U2OS cells and some of these proteins can activate the IRE1-XBP1 
pathway of UPR and IFNβ mRNAs suggestive of an active UPR, specifically the 
IRE1 arm and innate signaling respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18: UPR induction by ectopic expression of TBE viral proteins: A) Anti-FLAG western blot 
showing expression of 10 TBE viral proteins B) spliced form of XBP1 and C) IFNβ mRNAs 
quantification by qRT-PCR, results presented as normalized to β-Actin and fold change over 
untreated U2OS cells – E.V= empty vector, (*p≤0.05, **p≤0.01, ***p≤0.001, one-way ANOVA 
test). 
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3.3 UPR induction and Innate signaling by candidate TBE proteins E, NS1 and 
NS2B 
From the above findings, the identified TBEV viral proteins E, NS1 and NS2B were 
analyzed further in the context of UPR induction and innate signaling and then 
subjected to TBEV infection. The prM protein was not included in further 
investigation because while it could significantly induce IFNβ, the same wasn’t 
true for XBP1s admittedly this could just be a consequence of varying efficiencies 
between experiments. Nonetheless, the fact that prM is a glycoprotein same as E 
and NS1 proteins as opposed to NS2B, the effects of UPR induction as a 
consequence of expression of a glycoprotein at least for the purposes of this 
study were more than adequately represented by the two. However, this is not 
to say prM should be completely omitted for investigation in other aspects 
pertaining to similar interests as those of this project. Although showing an 
upward trend in the induction of both XBP1s and IFNβ, NS2A was also 
disregarded from further analyses, as these inductions were not statistically 
significant (Fig. 18B, C) 
As stated previously, E protein and NS1 are glycoproteins and ideally, during 
their formation require the endoplasmic reticulum where they undergo folding 
and further modifications in the Golgi before being secreted. This in essence also 
means their overexpression is therefore quite targeted and indeed more 
successful in overloading the ER, thereby inducing stress and ultimately resulting 
into the induction of the unfolded protein response.   
Conversely, NS2B, being a transmembrane protein whose most widely studied 
function has been as the co-factor to NS3 and therefore contributing to protease 
activity of the NS2B3, poses some intrigue in its ability to induce UPR. This is 
partly due to its lack of properties for direct UPR induction as compared to the 
glycoproteins thus favoring an alternative mechanism of UPR induction. 
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3.3.1 Expression of TBEV E, NS1 and NS2B proteins induces UPR  
The three candidate proteins (Fig. 18) identified from the screen of TBE viral 
proteins were expressed again in subsequent experiments (Fig. 19A) and tested 
initially for their ability to induce several UPR markers in addition to XBP1s.  
As observed previously in the quantification of XBP1s by qRT-PCR (Fig. 18B), all 
three TBE viral proteins showed substantial splicing of XBP1 as compared to the 
empty vector by XBP1s mRNA quantification by qRT-PCR and by conventional RT-
PCR for XBP1 splicing (Fig. 19B). XBP1s RT-PCR is a qualitative method of 
analyzing XBP1 splicing, the PCR is performed with primers that amplify both 
spliced and unspliced forms of XBP1. The two forms can then be observed as two 
bands or a single band on an agarose gel indicating splicing and therefore an 
active UPR and lack of it, respectively. The existence of the two bands in an event 
of splicing is due to a 26bp difference between the spliced and unspliced forms 
of XBP1. This method provides a visual advantage that adequately reiterates 
and/or complements the qRT-PCR quantification (schematic diagram of 
amplification by both methods: Fig. 19B, upper panel).  
I additionally tested for EDEM1, a downstream marker of IRE1 activation and an 
ER-resident protein responsible for the disposal of misfolded proteins through 
the ER-associated degradation pathway (ERAD). EDEM1 was significantly induced 
by NS1 and NS2B as compared to the control (Fig. 19C), suggesting activation of 
the ERAD pathway at least by expression of these two TBE proteins. 
It is a known fact that an increasing protein load to the ER leads to an up 
regulation of chaperone and co-chaperone proteins so as to increase the ER’s 
protein folding capacity and bring back the ER homeostasis. For this reason, I 
tested for BiP, the major ER chaperone protein and a marker downstream of the 
UPR arm ATF6. Indeed, BiP was significantly up regulated by the expression of all 
three viral proteins (Fig. 19D) and so was the co-chaperone DNAJC3, a 
downstream effector of XBP1s (Fig. 19E). The PERK arm of UPR is responsible for 
protein translation halting and in cases of extreme ER stress, the pro-apoptotic 
protein CHOP alias DDIT3 is induced downstream of this pathway. As compared  
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to the control, the levels of CHOP/DDIT3, a pro-apoptotic protein and GADD34, a 
target protein for CHOP and a phosphatase that functions as a negative regulator 
of PERK through the dephosphorylation of eIF2α for protein translation halt 
recovery were significantly upregulated when all three proteins were expressed 
(Fig. 19F, G)  
These results indicate an activation of not just IRE1-XBP1 pathway of UPR but 
also other UPR genes that implicate the other two arms of UPR by this approach 
albeit at varying levels of induction by individual TBE proteins.  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A 
D 
B 
C 
E.V E NS
1
NS
2B TM
0
200
400
600
800
E
NS1
NS2B
TM
E.V*
**
**
D
N
A
JC
3 
m
R
N
A
 (r
el
at
iv
e 
fo
ld
 in
cr
ea
se
)E 
E.V E NS
1
NS
2B TM
0
25
50
100
200
300
E
NS1
NS2B
TM
E.V
*
*
ED
EM
1 
m
R
N
A
 (r
el
at
iv
e 
fo
ld
 in
cr
ea
se
)
E.V E NS
1
NS
2B TM
0
50
100
150
200
400
600
800
E
NS1
NS2B
TM
E.V
*
*
***
B
iP
 m
R
N
A
 (r
el
at
iv
e 
fo
ld
 in
cr
ea
se
)September	28,	2019	 2	
     E					NS1		NS2B	
FLAG	
	
	
β-Actin	
3 
XBP1u	
XBP1s	
GAPDH	
NS
2B
	
pc
DN
A	
E	 NS
1	
TM
	
2 
530	
XBP1	cDNA	
Unspliced	XBP1	
Spliced	XBP1	
XBP1s	Fw/Rv	
XBP1s	Rv	XBP1u	Fw	
RT	PCR	
qRT-PCR	
557	
E.V E NS
1
NS
2B TM
0
20
40
60
80
150
200
250
300
E
NS1
NS2B
TM
E.V
*
*
**
XB
P1
s 
m
R
N
A
 (r
el
at
iv
e 
fo
ld
 in
cr
ea
se
) 
		 75	
Results 
 
 
  
 
 
 
 
 
 
 
 
 
Figure 19: Expression of TBEV proteins E, NS1 and NS2B induces UPR A) Anti-FLAG western blot 
showing expression of E, NS1, NS2B B) XBP1 splicing; Upper panel; schematic presentation of RT-
PCR and qRT-PCR (lower left, blue box) primer amplification of XBP1, Lower panel; Gel 
electrophoresis showing XBP1 splicing after RT-PCR (red box) and XBP1s mRNA quantification by 
qRT-PCR (blue box) C) EDEM1 D) BiP E) DNAJC3 F) CHOP/DDIT3 and G) GADD34 mRNAs 
quantification by qRT-PCR. Results presented as normalized to β-Actin and fold change over E.V = 
empty vector (*p≤0.05, **p≤0.01, ***p≤0.001 unpaired, student’s t-test). 
3.3.2 ISG induction in response to expression of TBE viral proteins 
The UPR-driven antiviral signaling and maintenance of a robust antiviral state 
against TBEV is mediated by a subset of ISGs through IRF3 (Carletti and Zakaria et 
al., 2019). All the candidate proteins showed substantive potential in the 
induction of UPR (Fig. 19). Additionally, having observed that even 10 hours of 
sterile TM treatment can induce some amounts of antiviral ISGs (Fig. 14A-F) and 
the overall transfection time was approximately 16 hours, it was plausible to also 
check for the ability of the expression of the candidate proteins in inducing some 
antiviral ISGs. I selected from the strongest induced ISGs that were a result of the 
differential analysis in figure 13B, that is OASL, IFIH1/MDA5, IFI44, IFI44L 
(Fig.14A-D) as well as IFIT1 and Viperin (Fig. 14E, F) broad antiviral ISGs against 
flaviviruses.  
Indeed, all three TBE proteins significantly induced Viperin, IFIT1 and IFI44 as 
compared to the empty vector control (Fig. 20A-C) while only NS2B was able to 
significantly induce IFI44L (Fig. 20D). However, the ISGs OASL and IFIH1 were not 
induced to any significant amounts by any of the viral proteins (Fig. 20E, F) 
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These results suggest a selective induction of ISGs by TBE E, NS1 and NS2B 
proteins with NS2B being the strongest of the three proteins in the induction of 
Viperin, IFIT1, IFI44 and IFI44L ISGs.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 20: Expression of E, NS1 and NS2B leads to an induction of antiviral ISGs: qRT-PCR 
quantification of A) Viperin B) IFIT1 C) IFI44 D) IFI44L E) OASL and F) IFIH1 mRNAs. Results 
presented as normalized to β-Actin and fold change over E.V=empty vector (*p≤0.05, **p≤0.01, 
***p≤0.001 unpaired, student’s t-test) 
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3.4 Expression of E, NS1 and NS2B in the course of TBEV infection 
The UPR-driven antiviral state translates into an up regulation of antiviral ISGs 
and inhibition of TBEV and other flaviviruses of clinical importance (Fig. 14, 
Carletti and Zakaria et al., 2019). In line with this, I performed a TBEV infection in 
a time course experiment in this system of UPR induction by ectopic expression 
of E, NS1 and NS2B TBE proteins.  
3.4.1 Expression of E, NS1 and NS2B protein inhibits TBEV replication 
The experimental scheme in this case followed the same procedure as the 
performed in figures 19 and 20 with an additional step of infection. After an 
overnight transfection, I infected the cells with TBEV, MOI = 1 and replaced the 
infection medium with complete medium after 1 hour of incubation. I then 
collected supernatants, RNA and cell extracts at time points 0, 4, 8 and 24 hours 
after infection (approximately 16, 20, 24 and 40 hours respectively after 
transfection).  
500ng of RNA was used for cDNA synthesis followed by qRT-PCR quantification of 
TBEV mRNA and an anti-4G2 western blot for TBEV E protein expression was 
carried out. Supernatants were used to quantify viral yields by plaque assay as 
described in the Materials and Methods chapter. 
After 8 hours of infection, there was a significant reduction of TBEV viral yields in 
the conditions of expression of E, NS1 and NS2B proteins as compared to the 
empty vector as well as untransfected cells. This was also true after 24 hours of 
infection, notably with increased virus production across all conditions as would 
be expected at this time point (Fig. 21A).  
This phenotype is additionally corroborated with the decreased amounts of TBEV 
at the protein level as can be observed by an anti-4G2 western blot where in the 
conditions of ectopic expression of E, NS1 and NS2B at 24 h.p.i, TBEV E protein 
due to infection is less than that of empty vector and/or TBEV infection alone, 
whose amounts are quite comparable (Fig. 21B).  
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Figure 21: Expression of E, NS1 and NS2B inhibits TBEV A) TBEV yields quantification by plaque 
assay in PFU/ml C) Anti-4G2 western blot showing TBEV E protein expression at 24 h.p.i, middle 
panel inserted to show expression under TBEV+TM condition (*p≤0.05, **p≤0.01, ***p≤0.001 
unpaired, student’s t-test) 
3.4.2 Expression of E, NS1 and NS2B proteins induces some antiviral ISGs during 
TBEV infection  
The next set of experiments was prompted from the observations that TBE viral 
proteins E, NS1 and NS2B can induce both UPR and some antiviral ISGs (Fig.19, 
20), but more importantly was the observation that there was TBEV inhibition in 
conditions of expression of the three proteins. I wanted to check whether this 
inhibition was due to a UPR-driven antiviral state that is facilitated by ISGs. 
From the RNA samples in the experiment shown in figure 21, I tested for the 
same ISGs that were previously tested (Fig. 14, 20).  
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Generally, the expression was not as strong as was observed by transfection 
alone (Fig. 20) and this was to be expected due to an increased length of time 
since transfection because until the 24th hour post infection, it is approximately 
40 hours of transfection and being a transient transfection, the number of 
transfectants are most likely dwindling at this point. Additionally, TBEV might 
have strategies to inhibit the expression of these antiviral genes, a state that is 
magnified and augmented with the increasing TBEV multiplication at this time 
point. It is therefore quite possible that at this time, the virus is overpowering 
the cell machinery in the experimental setting employed. 
Despite this fact, there was notable induction of IFIT1, Viperin and IFI44L mRNAs 
by only NS2B as compared to the empty vector and/or untransfected cells at 4 
and 8 hours after infection (Fig. 22A, B, C). Additionally, while transfection alone 
could not induce OASL (Fig. 20E), at 4 hours of infection, it showed an up-
regulation trend by all three proteins but only significantly by NS2B (Fig. 22D). 
However, at 4 and 8 hours post infection, all proteins could sufficiently induce 
significant amounts of IFI44 (Fig. 22E) and IFIH1 was not induced by any of the 
proteins (Fig. 22F) like it was the case with transfection only (Fig. 20F) 
Despite a general less expression as compared to transfection alone (Fig. 20), it 
seems that the ISGs induced by transfection of the proteins is maintained until 
few hours into infection (Fig. 22) and the effect is enough to inhibit TBEV even 
until 24 hours post-infection (Fig. 21). 
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Figure 22: Expression of E, NS1 and NS2B proteins induces some antiviral ISGs during TBEV 
infection A) qRT-PCR quantification of IFIT1 B) Viperin C) IFI44L D) OASL E) IFI44 and F) IFIH1 
mRNAs at 4, 8 and 24 time points after TBEV infection. Results presented as normalized to β-
Actin and fold change over T0 time point. E.V=empty vector (*p≤0.05, **p≤0.01, ***p≤0.001 
unpaired, student’s t-test) 
3.5 NS2B together with RIG-I augment IFNβ promoter activity 
A successful innate response relies on the recognition of viral molecular 
signatures (PAMPs) by specialized cellular receptors (PRRs) that are unique to 
the said signature. After this recognition event ensues a signaling cascade that 
encompasses RLR conformational changes and a recruitment of an adaptor 
protein that is dictated by the initial signal. Adaptor proteins converge at IRFs 
such as NF-κB and in the case of TBEV, IRF3, the activation of which depends on 
its phosphorylation by kinases that are deployed in the cascade. The culmination 
of this complex series of events is the translocation of phosphorylated IRF3 that 
activates IFNβ molecules and consequently ISGs that are the actual antiviral 
effectors. However, some ISGs can be induced as a direct consequence of 
activated IRFs (Fig. 8).  
RIG-I recognizes the dsRNA intermediates during TBEV infection. Induction of 
IFNβ and/or ISGs that characterize the UPR-driven antiviral state (Fig. 11,14) 
depends on IRF3 activation, which in retrospect depends on the initial PRR-PAMP 
recognition event and in this case, the RIG-I receptor. For this reason, it was 
plausible to check whether NS2B being the strongest ISG inducer (Fig. 20, 22), 
participates in the signaling and/or the mechanism of action of the IFNβ  
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promoter and the resulting effect on the promoter when expressed together 
with RIGI. 
I took advantage of the well-studied IFNβ Luciferase reporter system and the 
high efficiencies of transfection that can be achieved in HEK293T cells since the 
readout is solely contingent on what is transfected into the cells and not any 
cellular responses. Briefly, HEK293T cells were transfected with plasmids 
encoding NS2B, RIG-I, or both together with a reporter plasmid carrying the 
firefly luciferase (Fluc) gene under the control of the IFNβ promoter. The same 
was done with an empty vector in place of NS2B. After an overnight transfection, 
cell lysates were collected at approximately 16 hours of total transfection time. 
In every experiment and/or analysis, all samples were analyzed in duplicates and 
the relative luciferase activity was normalized to total protein concentration in 
each condition. Total protein concentration was quantified by Bradford assay as 
described in the Materials and Methods chapter. 
 As can be observed in figure 23A, all transfected components were successfully 
expressed as confirmed by an anti-FLAG western blot. The IFNβ promoter activity 
was significantly up regulated when NS2B was transfected and even more so 
when only RIG-I was transfected. However, when both NS2B and RIG-I were co-
transfected, there was a drastic increase in the IFNβ promoter activity, 
significantly more than either NS2B or RIG-I transfections alone (Fig. 23B).  These 
results are indicative of an inherent ability of NS2B to potentiate RIG-I activity on 
the IFNβ promoter and innate signaling. Additionally, it accentuates the UPR-
driven activity of NS2B and its role in innate signaling. 
 
 
 
 
 
 
 
 
		 83	
Results 
 
 
 
 
 
 
 
 
 
 
Figure 23: Expression of NS2B with RIG-I augments IFNβ promoter activity A) Anti-FLAG western 
blot showing expression of RIG-I and NS2B and B) Luciferase assay showing the IFNβ promoter 
activity after expression of NS2B and RIG-I expression, an empty vector (E.V) was used as a 
control. (**p≤0.01, ***p≤0.001 unpaired, student’s t-test) 
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Flavivirus infections have devastated mankind at least since the 18th century with 
the record of the first dengue-like epidemic in Asia, Africa and North America 
between 1776 and 1780 (Gubler, 1998; 2002). Subsequently, the importance of 
Flaviviridae has increased well into the 21st century with over 40 discovered 
pathogens within the family causing a myriad of infections affecting global 
populations both in morbidity and mortality rates. 
The struggle in the control of flaviviral infections is largely owed to the rapid 
evolving nature of viruses in general and even more so, RNA viruses. Viruses 
continuously evolve to evade host cell responses. The interplay between viruses 
and the innate immunity is therefore becoming excessively important, the 
understanding of which is fundamental in the search for sustainable control of 
viruses in terms of both vaccines and therapies. 
4.1 UPR as an innate immunity signaler 
UPR has been extensively studied as a homeostasis process to remediate 
consequences of ER stress. However, there is a vast wealth of knowledge 
implicating ER stress and several UPR genes in chronic non-communicable 
diseases ranging from diabetes to cancer as well as a multitude of autoimmune 
disorders (Morito and Nagata, 2012; Barrera et al., 2018; Madden et al., 2019, 
Walczak et al., 2019). Generally, the UPR is quite dynamic with different but 
systematically integrated actors orchestrating an attempt to recover ER 
homeostasis. Different ER stress stimuli at varying lengths of exposure activate 
different UPR sensor(s), in different kinetics and activation patterns. Ultimately, 
there’s different signaling to the downstream effector UPR genes and put 
together all these factors define the fate of the cell (Hetz et al., 2015, 2018). This 
systematically designed system also somewhat applies to viruses in their ability 
to activate different arms and /or take advantage of one or more arms because 
the stimuli and other surrounding factors somewhat dictate the ultimate 
outcome.  
In the recent past, the role of ER stress and UPR in infections and of particular 
interest viral infections is being actively explored. Viruses being dependent on  
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the host cell machinery disturb the functioning of the cell and particularly the ER. 
While serving as a remedial process, it is quite possible to imagine how the UPR 
can also be a danger signal in response to this disruption of cellular processes by 
viral infections. Indeed, it has been proposed that the UPR can act to potentiate 
immune system responses and specifically antiviral signaling (Smith, 2018) 
This is the case in flaviviral infections and extensive studies in our laboratory 
have proven the central role of UPR in innate immune signaling. Infections with 
multiple flaviviruses, have shown an induction of UPR much earlier before innate 
signaling. Without any intervention, innate signaling only kicks in at around 16 
hours after infection. However, when pre-activated, the UPR potentiates an 
earlier and more robust antiviral state that significantly inhibits clinically 
important flaviviruses (Carletti and Zakaria et al., 2019) 
This is the basis of the study reported herein and sets the precedent on which 
this work builds on. My doctoral work has focused on UPR-induced antiviral 
signaling taking into consideration all our vital findings especially the strong 
induction of ISGs that plays a significant role of the antiviral signaling (Fig. 14) 
and indeed the involvement of RLR-sensing in this antiviral signaling that is owed 
to the UPR.   
4.2 Pharmaceutical induction of UPR on cellular viability and growth. 
Our findings presenting evidence to these facts have been obtained from 
experiments performed with chemical inducers of UPR. These are chemicals 
designed to disrupt the functioning of the endoplasmic reticulum and in doing so 
interrupting normal activity of the ER, inducing stress and ultimately the UPR. 
Chemical UPR inducers get this done seamlessly but in some cases their effects 
may be widespread and pleiotropic. For this reason, there is always some 
concern on what the drugs do to the general functioning of the cell but also to 
the antiviral activity that is inherent to some of these drugs such as Tunicamycin, 
which is a naturally occurring antibiotic active against several viruses, bacteria 
and fungi (Foufelle and Fromenty, 2016).  
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With that in mind my first task was to rule out any excessive cytotoxic effects of 
Tunicamycin and Tharpsigargin on cell growth. Ideally, any experimental 
outcome of a UPR study depends on but not limited to drug concentration, 
cellular system used, and more importantly the research questions to be 
answered. For the sake of our studies, the concentrations we use have to be 
strong enough to induce a notable UPR response without overshadowing the 
resulting antiviral response in that it has to be possible to distinctly separate the 
antiviral response that is a result of UPR from any activity that is intrinsic to the 
drug such as TM. Additionally, ours being infection experiments, the 
concentrations used should be ones that do not overpower the system; cells 
need to remain viable enough to support both cellular function and virus 
infection for the length of the time course.  
I was able to show that the concentrations we use for both drugs indeed slow 
down the cell growth but without significantly impacting viability.  Average cell 
viability ranged between 95% to 100% (Fig. 12C) and growth picked up over time 
in the course of 32 hours as was shown by cell counts (Fig. 12B). The same was 
true for the amplification of β-Actin and GAPDH genes (Fig. 12D). While the 
expression of these genes could be regulated differently in the presence of UPR 
inducers, the values were not variable compared to my untreated controls all 
through the time course except for GAPDH at 24 hours after treatment. This was 
eventually more like the other conditions at 32 hours and this difference was not 
significant. While this may have just been an odd spike that was probably 
inconsequential to qRT-PCR data normalization, subsequent data was normalized 
to β-Actin that was more consistent throughout the time course with the 
exception of XBP1s RT-PCR that used GAPDH as control (Fig. 19B).  
4.3 The pursuit for alternative UPR induction methods 
Next came the search for and testing of several alternatives for their ability to 
induce ER stress and UPR with an aim to eventually minimize or eliminate the 
use of pharmaceutical inducers that we, like the rest of the UPR field have been 
accustomed to. Eventually, to check whether this would recapitulate the  
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induction of antiviral signaling that was a product of UPR induction in the course 
of flavivirus infections (Carletti and Zakaria et al., 2019). 
Simply put, ER stress and UPR induction happens when there is chaperone 
malfunction, impaired post-translational modification, difficult-to-fold client 
proteins (Marciniak et al., 2015) among other factors. In the classical model of ER 
stress and UPR activation, one or more of these factors ultimately leads to a 
rather direct increase in the intrinsic protein load. The same is true when the ER 
is provided with an ectopic load of unfolded and/or misfolded proteins. 
However, it has been suggested severally that activation of the IRE1 arm of the 
UPR may happen independently of this classical induction as would happen in B-
cell development where the response is not due to secretory protein overload 
but rather a developmental switch as an anticipatory move to be ready for 
protein folding of the large incoming load (as reviewed by Walter and Ron, 
2011). Sundaram et al., 2018 also observed a direct interaction of IRE1α with 
misfolded secretory proteins and activate preformed IRE1α complexes under 
conditions of ER stress, stressing on what would be a minor role of BiP in such 
cases.  
The approaches and experiments reported herein have mostly relied on 
providing the ER with an overload of proteins aiming to imitate the classical 
model, but not omitting the possibility of an alternative model of UPR induction. 
What is more relevant however is whether this induction would translate into 
innate signaling and virus inhibition. 
The depletion of BiP by siRNA (Fig. 15) while not as potent as TM was enough to 
induce significant XBP1s (Fig. 15B) seemingly in line with its function of the 
sequestration of UPR sensors. The same was true for the induction of IFNβ (Fig. 
15C) as was our hypothetical model. However, on the contrary, the viral yields 
were the same for both the knockdown and control conditions (Fig. 15D). While 
not following the model to the letter, the increase in virus titres is not 
completely surprising; knock down of BiP has previously been shown to increase 
the replication of Hepatitis A virus (HAV), this effect was augmented when BiP 
was knocked out by CRISPR/Cas 9 in Huh7 cells (Jiang et al., 2017). The same has  
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been proposed for Hepatitis B virus whose titres increased when BiP was 
depleted in HepG2 cells (Ma et al., 2009; Zheng et al., 2017). While these studies 
were not interested in UPR, their findings may partially provide some insight into 
the observed increase in virus titres (Fig. 15D). Knocking down BiP is probably 
only enough to induce ER stress and then UPR but this induction is not enough to 
render the system competent to inhibit TBEV.  
On the other hand, the use of BiP mutants could not induce XBP1s (Fig. 16B) or 
IFNβ (Fig. 16C). One explanation at least for the earlier would be the 
compensation by an up regulation of intrinsic BiP, other chaperones and co-
chaperones in the case of expression of the mutants. This was an observation in 
a study by Luo et al., 2006 that showed an up regulation of PDI and GRP94 in 
Grp78+/− mutant mice when compared to their wild-type counterparts in a set-up 
where BiP activity was considered to be at about 50%. On the other hand, the 
role of endogenous BiP cannot be underscored either; transient transfection 
employed in this case was probably not enough to overcome the role of intrinsic 
BiP in protein folding. Experimentally though, the ER stress or UPR as measured 
in this experiment relied on XBP1s as the readout, taking into consideration the 
struggle with superior transfection efficiencies and what may be the role of 
endogenous BiP, another perhaps indirect UPR readout would probably be more 
appropriate.  An experimental set-up that would allow a co-transfection of BiP 
and/or its mutants with a secretory protein would enable an assessment of the 
protein folding ability of the WT versus the mutants by quantifying not only the 
classical markers but also establish the collective amount of unfolded proteins 
bound to BiP which would probably be less in the WT than in the case of 
mutants. Such alternatives to study UPR have been reviewed by Lajoie et al., 
2014.  
Despite the possibilities and ideas outlined to improve the experimental set-up, I 
did not pursue this route of targeting BiP any further partly because of the 
challenge that I continuously experienced in transfection of U2OS cells as 
explained earlier which would make a co-transfection that much more limiting.  
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At the same time, I was looking into other approaches that at the time seemed 
more feasible. 
The approach of expressing NHK to induce ER stress and UPR is largely supported 
by data based on study of diseases involving the serpin family of protease 
inhibitors and/or interest in ER stress in diseases specifically implicating the 
ERAD pathway. The overexpression of NHK, a cellular truncated mutant of α1AT 
has been shown to activate the XBP1-IRE1 pathway and is an appropriate 
substrate of ERAD, a pathway that serves to dispose off misfolded proteins 
(Hosokawa et al., 2001; Ordoñez et al., 2013; Jang et al., 2015). EDEM proteins 
play a major role in the first steps of substrate recognition of NHK and other 
misfolded proteins and this is crucial for efficient degradation in the ERAD 
pathway (Jang et al., 2015).  
While also not as potent as TM, NHK expression was able to induce considerable 
XBP1s mRNA as compared to its wild type control (Fig. 17B) and this difference 
was complemented by the observation of more secreted α1AT than NHK 
suggesting its accumulation (Fig. 17A). However, there wasn’t significant 
induction of IFNβ, which has previously characterized the UPR-driven immune 
response. This however was not reason enough to suspend further experiments 
considering that XBP1s was significantly induced which fulfilled the minimal 
requirement but also from previous experiments, TM and TG themselves can 
induce only minimal IFNβ in the absence of infection (Figs.14, 15C, 16C, 17C).  
Upon infection, the lesser TBEV mRNA on expression of NHK as compared to 
α1AT was not significant and somewhat mirrored the induced IFNβ. In essence it 
is easy to think that the reduced TBEV mRNA trend observed is what caused the 
low IFNβ induction observed on expression of NHK (Fig. 17C, D) as opposed to an 
up regulation of IFNβ as a consequence of UPR that inhibits TBEV as observed in 
the TM positive control (Fig. 17E) and in previous experiments (Fig. 11B, C). As 
per our working hypothesis, UPR potentiates innate signalling that results to 
virus inhibition. This implies that success of the antiviral signalling and virus 
inhibition depends on and requires an active UPR. It has been previously 
established that dimers of NHK are much more aggregative than do monomers,  
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this is because ERAD has to disassemble dimers into monomers which are the 
actual substrates of EDEM proteins (Hosokawa et al., 2006) suggesting a longer 
retention of NHK dimers in the ER than its monomers. If the UPR observed in this 
experimental set-up on exogenous expression of NHK is due to monomer 
aggregates, it is plausible to speculate that the resulting response may be short-
lived and probably not enough to translate into proper IFNβ induction and TBEV 
inhibition.  
4.4 TBE viral proteins: viable UPR inducers 
It is common knowledge that multiple viral infections result into the activation of 
ER stress (He, 2006; Asha and Sharma-Walia, 2018). RNA viruses are no 
exception; in fact, most of the recorded ER remodeling as a result of virus 
infections is due to positive-stranded RNA viruses because their replication and 
assembly relies almost exclusively on the ER. Replication factories for viruses are 
a product of ER membrane invaginations that eventually provide physical 
support during replication and viruses additionally use them as protective shields 
from innate sensors, a strategy adopted by multiple flaviviruses (Romero-Brey 
and Bartenschlager, 2016, Miorin et al., 2012, 2013). This evidence points to the 
obvious and vital relationship between flavivirus infection and the ER and a 
direct link to ER stress during viral infection. A great deal of literature exists 
providing insights into stress responses and UPR in the course of flavivirus 
infections, including but not limited to the ways different flaviviruses modulate 
the response, which of the three arms are activated in response to specific 
viruses and aspects surrounding apoptosis, autophagy and generally the 
relationships and/or interplays during infection which many times influence 
disease pathogenesis (Li et al., 2013; Yu et al., 2013;Blázquez et al., 2014; Perera 
et al., 2017; Gladwyn-Ng et al., 2018; Tan et al., 2018; Alfano et al., 2019; Zhao et 
al., 2019). And while there is no doubt on the induction of ER stress by viral 
infection, all this information opens up an avenue for the inquisition into what 
could be a specific viral protein(s) responsible for inducing the response. The  
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screen of TBE proteins as a way of inducing ER stress and UPR was therefore an 
approach presenting an opportunity for both at least in TBEV infection.  
Indeed, ectopic expression of TBE viral proteins proved to be a feasible and 
worthwhile approach as it revealed multiple, viable candidates that could 
strongly induce ER stress and UPR, but also significant innate signaling (Fig. 18- 
20) same as was already observed in previous experiments that used 
pharmaceutical inducers of UPR (Fig. 14). While there isn’t much available 
literature-wise, the search for and identification of viral proteins that induce ER 
stress is not a completely untapped area (Brunner et al., 2012; Fung et al., 2015; 
Frabutt et al., 2018; Siddiquey et al., 2018)  
Glycoproteins such as E protein and NS1 being secretory proteins with a 
necessary requirement to go through the ER, provides them with a somewhat 
expected ability to induce ER stress in cases of ectopic expression, in fact, NS1 
glycoproteins of JEV and DENV2 have been shown to increase XBP1 splicing (Yu 
et al., 2006). Frabutt and colleagues (2018) showed the induction of ER stress by 
an up regulation of BiP and XBP1s mRNAs after IAV infection. They followed up 
and showed the specific potency of IAV HA in inducing XBP1 splicing using a 
luciferase-based reporter assay to measure IRE1-mediated XBP1 activation in 
transient transfection of HAs of IAV H1 and H5 subtypes as well as Env 
glycoproteins of HIV-1 of NL43, JRFL, and SF162 strains using NHK as a positive 
control. This analysis further revealed the specific involvement of the ERAD 
pathway and highlights on the glycosylation aspect of the proteins regulating ER 
stress and specifically phosphorylation of IRE1α that defines the host response 
and pathogenesis (Hrincius et al.,2015; Frabutt and Zheng,2016).  
The relevance of this is that different viral proteins of different viruses may 
indeed induce ER stress or fail to do so like was the case of some glycoproteins 
examined by Frabutt et al., 2018 and indeed in my analysis (Fig. 18).  But more 
importantly, it stresses on how ER stress is central in defining infection outcomes 
and pathogeneses in viral infections which makes it that much more vital in our 
understanding of viral infections and even more so as we dissect some 
mechanistic aspects of the processes involved therein.  
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What seemed like an odd candidate in this screen though is the NS2B protein. 
NS2B is one of the 4 small, membrane-anchored proteins of flaviviruses and 
unlike the glycoproteins; it does not require the use of the ER like glycoproteins 
do in fact, its hydrophobic terminal regions function to anchor the NS2B3 
protease to the ER membrane (Clum et al., 1997).  
Admittedly, ectopic expression of NS2B may indeed cause an overload of 
proteins to the ER but this could be by a different mechanism as opposed to the 
glycoproteins, which have the biochemical attributes to suggest that they can 
directly overload the ER as described previously.  While NS2B has not been well 
described in ER stress and UPR studies, NS2B3, the flavivirus protease complex 
responsible for several cleavages of the polyprotein has been observed to induce 
ER stress in DENV (Cheng et al., 2016) and much more than NS2B or NS3 alone 
(Yu et al., 2006). These two studies are both favoring the possibility of protease 
activity being involved in ER stress induction as opposed to what I have observed 
in my tests (Fig.18-19) 
This begs the question as to whether NS2B induces the UPR in a mechanism 
different from the classical one and this aspect is worth looking into especially 
with the accumulating literature implicating some non-structural proteins in the 
formation of replication complexes that are the hallmark of ER membrane 
rearrangements that accompany infection (Leung et al., 2008; Rothan and 
Kumar, 2019) and even more specific to TBEV, a polyprotein made up of all non-
structural proteins except NS5 has been proven to form replication complex-like 
structures independent of viral replication fortifying the knowledge that NS 
proteins drive the remodeling that accompanies infection at least in TBEV (Yau et 
al., 2019) NS2B proteins of DENV and JEV have been suggested to possess 
membrane permeability and destabilizing properties (Chang et al., 1999; León-
Juárez et al., 2016). While membrane remodelling per se has not yet been 
proven to induce UPR, the above findings may contribute to some of the 
speculation that NS2B could be one of the non-structural proteins involved in ER 
membrane rearrangements during infection. 
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It is important to restate the emphasis of IRE1 pathway in all the analyses carried 
out in this work. The IRE1 arm is the most conserved UPR transducer in yeast, 
plants and metazoans (Maurel et al., 2014). Apart from XBP1s being the classical 
marker of UPR activation as stated previously, the IRE1 is the effector of choice 
in the UPR-driven antiviral activity in the course of TBEV infection albeit using a 
mechanism that does not rely on its RNase activity which leads to splicing of 
XBP1 and IRE1-dependent decay of RNA (Carletti and Zakaria, 2019). And while 
this is the current hypothesis, it is admissible to probe into the involvement of 
one or both of the other arms since this is a different way of UPR induction as 
compared to TM. Indeed, I observed an up regulation of XBP1s by two different 
methods as well as its downstream effector of the ERAD pathway, EDEM1 by all 
three proteins (Fig.18, 19B, C). The upregulation of BiP, DNAJC3, CHOP and 
GADD34 (Fig. 19) by all three proteins may suggest a partial involvement by 
more than the IRE1 arm but this observation would be more concrete if the 
phosphorylation of PERK and/or translocation of ATF6 would be analyzed in 
these conditions in future experiments pertaining to this work.  
If indeed there is involvement of another arm of the UPR, this may be a 
consequence of individual expression of viral proteins as opposed to infection 
where multiple proteins may act in concert, modulating each other and 
somehow dampening or accentuating what could be an effect of a single protein 
as observed in this case and this logic goes for both induction of UPR as well as 
innate signaling.   
4.5 UPR-driven Innate signaling by E, NS1 and NS2B 
As discussed previously, the UPR is increasingly becoming important in innate 
signaling. An important aspect of the UPR-driven antiviral signaling during TBEV 
infection is the role played by ISGs. (Fig.14, Carletti and Zakaria, 2019). Some 
work has shown cross talks between certain arms of the UPR with the NF-κB 
pathway. Phosphorylation of eIF2α has been shown to activate canonical 
signaling of NF-κB, same as through the catalytic activity of IRE1 on treatment 
with TM or TG (Schmitz et al., 2018). Innate sensing that is UPR-driven or  
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modulated has been observed in multiple factors of the response suggesting an 
element of UPR being a danger signal in viral infection (Smith, 2014). 
The induction of ISGs following expression of viral proteins (Fig. 20) is therefore 
not completely surprising especially after having confirmed that expression of 
these proteins can induce UPR (Figs. 18, 19). Same as is the case in HCMV where 
cytokine stimulation can be mediated by interactions between envelope entry 
proteins and TLR2 (Boehme et al., 2006), the ability of individual viral proteins to 
induce some innate response and even more when viral proteins are 
overexpressed is not completely unlikely. 
The ISG induction after transfection of E protein, NS1 and NS2B while a 
significant observation, it was important to see whether this induction is 
maintained when cells were infected and more importantly if it inhibits the virus 
as was the case on infection and treatment with TM (Figs. 11, 14). Quite 
remarkably, the ISGs observed earlier (Fig. 19) are maintained for some time well 
into early hours of infection (Fig. 21), and visibly suppressing TBEV multiplication 
as analyzed by viral yield quantification and western blot (Fig. 22). Most notably 
is IFI44 that is induced by all 3 proteins after transfection until 8 hours after 
infection. The function of IFI44 is not well studied but has been shown to target 
HIV-1 LTR promoter activity facilitating viral latency (Power et al., 2015) and has 
additionally been speculated to be a natural homolog of Ribavirin, a potent 
known drug against HCV (Hallen et al., 2007). Ribavirin while quite potent in HCV 
inhibition, when tested in TBEV, it presented weak or no inhibition activity as 
opposed to other nucleoside analogues in the same studies (Eyer et al., 2015, 
Lenz et al., 2018).  In addition to IFI44, induction of IFIT1 and Viperin (alias 
RSAD2) was observed during transfection, but this induction was only sustained 
by NS2B until 8 hours of infection with TBEV. IFIT1 and Viperin are well known 
broad antivirals against viruses beyond the Flaviviridae family (Helbig and Beard, 
2014; Ng and Hiscox, 2018, Richard Lindqvist and Anna K. Överby, 2018) 
targeting viral protein synthesis and replication steps respectively (Fig. 7, 
Schoggins, 2019). IFI44L was only induced by NS2B on ectopic expression and 
this induction lasted until 8 hours of TBEV infection same as IFIT1 and Viperin.  
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Like IFI44, IFI44L is not a well-studied ISG but was identified in a FACS-based 
phenotypic screen of ISGs and proposed to have some antiviral activity against 
HCV (Schoggins et al., 2011; reviewed by Metz et al., 2013). It was also identified 
in a microarray analysis as one of the highly induced ISGs underlying inhibition of 
HIV-1replication by endogenous TRIM56 on treatment with IFNα (Kane et al., 
2016). 
Quite surprising though is OASL that is not induced with transfection but is 
significantly induced only at 4 hours after TBEV infection suggesting the 
possibility of involvement of an infection component in its induction, this 
induction proves to be a short-lived as it does not last longer than that. OASL 
belongs to the OAS family of ISGs, which in other mammals targets viral RNA for 
degradation by an enzyme RNAsel, which is lacking in humans. However, OASL 
has been suggested to promote antiviral activity by enhancing the sensitivity of 
RIG-I activation the sensor of dsRNA intermediates of infection (Zhu et al., 2014, 
2015) and favoring replication for some DNA viruses (Ghosh et al., 2017; Bussey 
et al., 2018) suggesting a differential activity in different infections.  
Whatever the mechanism of action and/or targets of these ISGs is beyond the 
current scope of this work but their collective effect seems to translate to TBEV 
inhibition and quite interestingly, while at 24 hours all the ISGs are not induced 
to any level of significance, the earlier effects of induction sustain TBEV inhibition 
until 24 hours after infection (Fig. 22). These results point to a role of ISGs in 
TBEV inhibition achieved by the UPR-driven activation by E, NS1 and NS2B 
proteins and pointing to NS2B as the protein with an ability of sustaining longer 
kinetics of ISG induction. Additionally, it brings forth IFI44 (Fig. 22E) as an 
important ISG that is induced by all the 3 proteins until 8 hours of infection and 
probably plays the most central role in TBEV inhibition at least in the conditions 
of E and NS1 expression (Fig. 21).  
4.6 TBEV NS2B, more than just a protease cofactor? 
A rather surprising aspect of this what work has been all the findings with NS2B 
(Fig.18-23). NS2B has stood out in its potency in inducing UPR and ISG induction  
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and presents us with an appealing and scarcely studied viral protein that future 
work may focus on.  
Having observed some of the strongest effects on UPR induction and ISG 
induction in the condition of NS2B expression (Fig. 18-20), the ability of NS2B to 
increase the IFNβ reporter activity was just another piece to the puzzle that is 
NS2B (Fig. 23B). This effect was highly significant when NS2B was co-transfected 
with the sensor RIGI that is the PRR of choice in TBEV infections. The ability of 
certain viral proteins to initiate the first wave of innate signaling has been 
suggested in the past (Mogensen and Paludin, 2001) as it would seem is the case 
with NS2B. And while RIG-I is constitutively expressed, albeit at low levels, its 
expression is enhanced by activation of IFN-α/β signalling that is also the case 
when NS2B is transfected (Fig. 23A, B).   
However, it would be interesting to understand the mechanism of action of NS2B 
and its link to the antiviral activity exhibited to a regulatory factor downstream 
of RLR-sensing such as IRF3. 
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4.7 Concluding Remarks  
In my doctoral study, I embarked on a journey to analyze the effects of current 
UPR inducers to cell growth in the experimental settings employed for most 
experiments reported herein and find alternatives if any for ER stress and UPR 
induction.  
The findings of this work have divulged a feasible approach of inducing UPR in 
U2OS cells using TBE viral proteins and in doing so gave us a way of narrowing 
down from 10 TBE viral proteins to what may be the culprits of UPR induction 
during infection. E protein, NS1 and NS2B proteins of TBEV may be the viral 
components that drive ER stress and UPR induction during TBEV infection. 
Moreover, they hold promise as tools to investigate the UPR in a more 
controlled, authentic stance and provide an alternative to the current 
pharmaceutical inducers.  
The induction of UPR by these proteins is accompanied by innate immune 
signalling and TBEV inhibition, complementing quite well recent findings from 
our laboratory (Carletti and Zakaria et al., 2019) highlighting a key role played by 
ISGs in the UPR-induced antiviral state achieved by treatment with TM (Fig. 13), 
as is observed in the expression of E, NS1 and NS2B viral proteins (Figs. 19, 20) 
Molecular mechanisms of action of these proteins in their induction of ER stress 
remains an area to be explored and while the mechanism of E protein and NS1 
can be speculated, NS2B is rather more fascinating in this case. This will provide 
more insights on flavivirus NS2B as a stand-alone protein quite distinctly from 
how it has been known and studied in literature under the shadow of the NS2B3 
protease complex.  
NS2B brings forth even more the notion that non-structural proteins may be key 
players in membrane rearrangements that accompany infection. Whether 
membrane remodelling is enough to induce UPR independent of infection 
remains a question to be answered but this question offers one line of 
speculation as to how NS2B may induce ER stress and UPR. The established 
ability of NS2B to up regulate the IFNβ promoter activity (Fig. 22) adds to a role it  
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plays in the collective innate signalling that is observed on transfection of this 
protein.  
Further probing into some of these aspects may be useful in establishing the 
mechanism(s) of UPR induction and innate signalling achieved on transfection of 
all proteins studied but even more so for NS2B, having confirmed that it acts in 
concert with RIG-I, the receptor of choice in TBEV infection.  
These factors make NS2B subject to more investigation and may add more to the 
gap of knowledge in the study of membrane rearrangements that is a common 
feature among flaviviruses.  
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The innate response to a pathogen is critical in determining the outcome of the infection.
However, the interplay of different cellular responses that are activated following viral
infection and their contribution to innate antiviral signalling has not been clearly established.
This work shows that flaviviruses, including Dengue, Zika, West Nile and Tick-borne ence-
phalitis viruses, activate the unfolded protein response before transcription of interferon
regulatory factor 3 induced genes. Infection in conditions of unfolded protein response
priming leads to early activation of innate antiviral responses and cell intrinsic inhibition of
viral replication, which is interferon regulatory factor 3 dependent. These results demonstrate
that the unfolded protein response is not only a physiological reaction of the cell to viral
infection, but also synergizes with pattern recognition sensing to mount a potent antiviral
response.
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F laviviruses are a family of relevant human pathogensdelivered by mosquitoes or ticks. Dengue virus (DENV),Zika virus (ZIKV), West Nile virus (WNV), and tick-borne
encephalitis virus (TBEV) are only few examples affecting tropical
countries and Europe1,2.
The genome of Flaviviruses is a single RNA filament of positive
polarity encoding a polyprotein precursor, which is processed
into structural and nonstructural proteins3. The RNA genome is
replicated by the viral RNA-dependent RNA polymerase through
a complementary template of negative polarity, which forms
transient double-stranded RNA (dsRNA) intermediates. Infection
induces important rearrangements of cytoplasmic membranes of
the endoplasmic reticulum (ER) with the formation of char-
acteristic replication vesicles containing dsRNA and replicative
proteins4–6.
Target cells respond to viral infection by activating innate
defense mechanisms. Cytoplasmic pattern recognition receptors
(PRRs) recognize viral RNA intermediates as pathogen-associated
molecular patterns (PAMPs) to trigger the interferon (IFN)-
mediated antiviral response7. The innate immune response is
generally associated to the activity of IFN leading to the induction
of interferon-stimulated genes (ISGs) endowed with antiviral
activity. However, at very early time points post infection, cell
intrinsic mechanisms of defense play an important role in med-
iating an antiviral response, while IFN remains essential to pro-
tect neighboring uninfected cells and to contain the spread of
infection.
Virus infection can also lead to ER stress by unscheduled
accumulation of viral proteins or modification of ER membranes.
Accumulation of unfolded or misfolded proteins in the ER leads
to a stress response by activating the unfolded protein response
(UPR) pathway, which restores ER homeostasis8,9. Three trans-
membrane ER proteins mediate the UPR: the inositol-requiring
enzyme 1 (IRE1), the protein kinase RNA-like ER kinase (PERK),
and the activating transcription factor 6 (ATF6). Activated IRE1
cleaves the X-box binding protein 1 (XBP1) mRNA in the cyto-
plasm leading to the spliced form, which is translated into an
active transcription factor (XBP1s). Activated PERK phosphor-
ylates the eukaryotic translation initiation factor 2α (eIF2α)
causing inhibition of protein synthesis, but also enhanced trans-
lation of the activating transcription factor 4 (ATF4). ATF4 in
turn promotes transcription of several genes including the
CCAAT/enhancer-binding protein-homologous protein (CHOP),
a proapoptotic transcription factor, and feedback regulators,
which counteract the phosphorylation of eIF2α. Activation of the
ATF6 pathway leads to the processing of ATF6 into a cleaved
product that translocate to the nucleus to activate UPR-regulated
genes including Xbp1.
It has been previously shown that sterile co-stimulation of the
UPR with certain PAMPs such as lipopolysaccharide or Poly-
inosinic:polycytidylic (poly I:C) acid greatly potentiates the
expression of IFNβ10–12. These observations led to the intriguing
hypothesis that UPR and PRR signaling synergize during infec-
tion to provide optimal antiviral immunity13.
In this work, transcriptome analysis of TBEV infected cells
shows upregulation of a number of genes involved in the UPR.
Careful temporal analysis demonstrates that the IFN response is a
late event preceded by the UPR. Most importantly, preactivation
of the UPR during flavivirus infection causes a decrease of viral
titers, an earlier induction of IRF3 phosphorylation and translo-
cation, and of IFN and ISGs transcription. IRF3 depletion rescues
flavivirus replication induced by UPR priming. Furthermore,
depletion of IRE1, but not of ATF6 or PERK, enhance viral
replication and rescue specifically TBEV from antiviral priming of
the UPR. This IRE1 function is independent of its RNAse activity,
but dependent on IRF3 and RIG-I. Hence, these data demonstrate
that the UPR is a very early cellular response to TBEV infection,
which triggers an IRF3/RIG-I dependent cell intrinsic antiviral
response through IRE1.
Results
Transcriptome analysis of TBEV infection. In previous studies a
consistent delay of the IFN beta (IFNβ) response, following fla-
vivirus infection, was described14,15. Viral replication could be
detected as early as 8 h post-infection (h.p.i.), while IFNβ mRNA
appeared only after 16 h.p.i. Starting from this observation, in
order to investigate the cellular pathways that could be activated
in the infected cells before IFNβ induction, an unbiased tran-
scriptome analysis of infected cells was conducted. Newly syn-
thesized TBEV RNA was already high as early as 10 h.p.i., a time
point, when IFNβ mRNA could not be detected. As expected,
IFNβ mRNA was eventually upregulated at 24 h.p.i. These two
time points were chosen to conduct the transcriptome analysis of
the infected cells. Total RNA was extracted from infected cells in
triplicate independent experiments and subjected to high-content
sequencing. Differential analysis of the transcriptome of U2OS
cells infected with TBEV at 24 versus 10 h.p.i. showed significant
upregulation of 437 genes (fold change ≥2) and downregulation
of 318 genes (fold change ≤2) with a false discovery rate of <0.05
(DESEQ2 statistical analysis) (Fig. 1a). Ingenuity Pathway Ana-
lysis (IPA) indicated the UPR as the most highly significant
canonical pathway (−log (p-value)= 7.37) followed by ER stress
(−log (p-value)= 3.93). Several genes showed upregulation,
including HSPA5 (Heat-Shock 70 kDa Protein 5, BiP), Xbp1/
Xbp1s, DDIT3 (CHOP), and the chaperones DnaJ (Hsp40)
Homolog, Subfamily C, Member 3 (DNAJC3/P58IPK), and Sub-
family B, Member 9 (DNAJB9). To conclude, significant early
activation of UPR-related genes was observed during TBEV
infection.
UPR is induced before the interferon response following
infection. The kinetics of UPR induction was analyzed tempo-
rally following TBEV infection. As shown in Fig. 1, TBEV
infection of U2OS cells was productive as early as 10 h.p.i.
(Fig. 1b) with TBEV RNA being detectable at 8 h.p.i. (Fig. 1c). At
variance, IFNβ mRNA appears only after 16 h.p.i. (Fig. 1d). UPR
genes such as Xbp1, DNAJC3, and DNAJB9 also appear at late
time points, concomitantly with IFNβ mRNA (Fig. 1e and Sup-
plementary Fig. 1A and 1B). However, the spliced form of Xbp1
mRNA, an indicator of IRE1 activation, could be detected as early
as 12 h.p.i. (Fig. 1f). Similarly, the PERK-dependent activation of
CHOP occurred before the IFNβ response (Fig. 1g). Indeed,
PERK phosphorylation could be detected at 8 h.p.i. followed by
phosphorylation of the eIF2α (Fig. 1h). The third arm of the UPR
response is initiated by nuclear translocation of ATF6. To
monitor the ATF6 pathway, GFP-ATF6 was transfected in U2OS
cells followed by TBEV infection16. As shown in Supplementary
Fig. 1C and quantified in Fig. 1i, translocation of GFP-ATF6 into
the nucleus of infected cells occurred from 8–12 h.p.i. Con-
sistently, UPR genes that are activated downstream of the ATF6
pathway, such as BiP (Fig. 1j), were also induced following TBEV
infection.
Induction of UPR leads to early activation of an innate anti-
viral response during flavivirus infection. To summarize the
above findings, all three arms of the UPR were activated at early
time points following TBEV infection, prior to IFNβ induction.
Therefore, the UPR could be a prerequisite for a proper antiviral
response. To address this hypothesis, U2OS cells were exposed to
Tunicamycin (TM), a well-known inducer of the UPR, immedi-
ately after TBEV infection. As shown in Fig. 2a, b, viral yields and
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viral RNA were markedly reduced following TM treatment. Since
TM inhibits N-linked glycosylation and could potentially affect
viral infectivity, viral RNA levels were also investigated. To note,
at 8 h.p.i., while viral yields were not yet increasing (Fig. 2a), there
was a significant inhibition of viral replication in the presence of
TM (Fig. 2b), demonstrating that this early antiviral effect is
independent of any unspecific activity on the glycosylation of
viral proteins. As a control of TM activity, Xbp1s mRNA was also
induced at early time points in the presence of TM (Fig. 2c).
Interestingly, induction of IFNβ mRNA occurred much earlier
following preactivation of the UPR. As shown in Fig. 2d, treat-
ment of U2OS cells with TM alone (gray bars) stimulated a weak
tenfold increase of IFNβ mRNA only after 24 h of treatment.
However, upon both TBEV infection and TM treatment, IFNβ
was clearly induced as early as 8 h.p.i. (white bars).
To rule out any unspecific effect of TM, the same approach was
repeated using Thapsigargin (TG), which activates UPR by
blocking the ER calcium ATPase. As shown in Supplementary
Fig. 1D and E, both TM and TG inhibit TBEV, but, while TM
showed a partial effect on E protein glycosylation as expected, TG
did not affect the viral protein. TG was first verified for being able
to induce Xbp1s in U2OS at the concentration used (Supple-
mentary Fig. 1F). Next, cells were infected with TBEV followed by
treatment with TG. As shown in Fig. 2e, f, TG behaves similarly
to TM in inducing an early IFNβ response and inhibiting virus
yields. As observed with TM, IFNβ mRNA was induced at low
levels by TG alone after 24 h of treatment, but synergized with
TBEV infection to potentiate the innate response.
A similar analysis was conducted on other members of the
flavivirus family such as DENV2 (Fig. 2g, h), WNV (Fig. 2i, j),
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Fig. 1 Temporal analysis of the UPR response to TBEV infection. a Difference in total transcript expression following TBEV infection. Total RNA was
extracted from TBEV infected cells at 0, 10, and 24 h.p.i. in triplicate independent experiments and processed for high-content sequencing (∼24.6 million
reads for each time point). The volcano plot shows the differential gene expression at 24/0 versus 10/0 h.p.i. Horizontal and vertical dashed lines indicate
cutoff values (FDR value of 0.05 corresponding to 1,30 Score and absolute logarithmic fold-change >2, respectively). Genes having a significant altered
expression are emphasized in red (upregulated) and green (downregulated). Upregulated hits from the UPR pathway are encircled in blue. b Time course
of viral yields. U2OS cells were infected with TBEV at moi= 1. Supernatant from infected cells were used to infect Vero cells to measure virus yields
(PFU/ml). c–g, k Time course of viral RNA and UPR-related mRNAs. U2OS cells were infected as in b. Total RNA extracted at the indicated time points and
used as template for qPCR using primers specific for TBEV (5′-NCR) (c). TBEV RNA amplification products were normalized to β-actin RNA and plotted as
fold change from time 0. Data and statistics are plotted as in Fig. 1b. The same protocol was used to quantify mRNA of IFNβ (d), Xbp1 (e), Xbp1s (f), CHOP
(g), and BiP (j). h Time course of PERK activation. U2OS cells were infected with TBEV at moi= 1. At the indicated time points, the total protein content
was extracted and subjected to immunoblotting with the indicated antibodies. jTime course of ATF6 translocation. Cells treated as in (b) were quantified
for ATF6 nuclear translocation. GFP positive cells were manually counted for ATF6 nuclear translocation at each time point. The graph shows the results
from two independent experiments, 200 cells for each time point. Typically three biologically independent experiments (n= 3) in triplicate repeats were
conducted for each condition examined. Average values are shown with standard deviation and p-values, measured with a paired two-tailed t-test.
Significant p-values are indicated by asterisks (**p < 0.01; *p < 0.05). Source data are provided as a Source Data file
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and ZIKV (Fig. 2k, l). Likewise, induction of the UPR by TM
resulted in a decrease of virus yields and an early IFNβ response
demonstrating that early activation of the UPR leading to a
sustained IFNβ response is a general mechanism within
flaviviruses.
The UPR-induced antiviral response is independent of cano-
nical interferon signaling. Since early IFN activation was con-
sistently observed following flavivirus infection in the presence of
UPR inducers, it was plausible to hypothesize that the decrease of
virus titers could depend on interferon-dependent antiviral sig-
naling. In order to address this, primary embryonic murine
fibroblasts, derived from IFN receptor knockout mice (MEF
ifnar-/-), were infected in the same experimental conditions.
Noteworthy, as shown in Fig. 3, wild-type MEF reproduced the
same phenotype observed as in U2OS cells, reinforcing the
previous observations also in a nontransformed primary murine
cell model. MEF ifnar-/- showed an antiviral response and an
early induction of IFNβ in the presence of TM, which was
kinetically similar to that observed in wild-type MEFs (Fig. 3a, b).
This observation points to an IFN-signaling independent antiviral
activity.
A subset of ISGs, with antiviral activity, that are known to be
induced directly by the transcription factor IRF3, have been
previously described17,18. IRF3 phosphorylation, measured fol-
lowing infection, occurred at earlier time points and to a greater
magnitude in TM-treated cells as compared with control (Fig. 3c).
Consistently, nuclear translocation of IRF3 was significantly
increased at 8 h.p.i. compared with infection alone in the same
experimental conditions (Fig. 3d, e). Transcriptional induction of
IRF3-dependent ISGs, such as IFIT1 or Viperin, showed early
activation kinetics in the presence of TM, comparable with what
was observed for IFNβ, (Fig. 3f, g).
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In order to better characterize this phenomenon a transcrip-
tome analysis was conducted on: (i) cells infected with TBEV at 8
h.p.i.; (ii) cells treated with TM for 8 h and (iii) cells both infected
and treated with TM at the same time point. IPA indicated the
UPR as the most highly enriched canonical pathway (p-value=
7.97−12) induced by sterile TM treatment, while for TBEV
infected cells alone at 8 h.p.i. no enriched pathways were
indicated, which is in line with the observation that UPR is
activated from 10 h.p.i. (Fig. 1). IPA indicated ‘activation of IRF
by cytosolic PRR’’ as the most highly enriched canonical pathway
(p-value= 3.04−05) for the dataset of cells infected with TBEV
and treated with TM. Other top-ranked pathways were ‘inter-
feron signaling’’, ‘role of PRRs in recognition of bacteriae and
viruses’’, and ‘role of RIG-I like receptors in antiviral innate
immunity’’ strongly supporting the hypothesis. Differential
analysis of the two groups, i.e., treated with TM alone and
infected +TM, indicated that the 39 genes that were differentially
modulated in the two conditions partition in two functional
clusters that defined each condition as clearly visible in the
heatmap (Fig. 3h). The cluster of genes differentially regulated
during infection in conditions of UPR induction showed a high
prevalence of ISGs. In particular ISG15, IFI6, IFI44L, IFI44,
IFIH1, DDX60, SAMD9, SAMD9L, ZC3HAV1, PARP10,
DDX58, and OASL have been already described as antiviral
effectors19–23. A subset of these ISGs that include OASL, IFIH1,
IFI44, and IFI44L have been validated by RT-qPCR
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Fig. 3 UPR-induced antiviral signaling following infection is independent of interferon signaling. a Tunicamycin treatment inhibited TBEV yields
independently of IFNAR. Primary embryonic MEF Ifnar-/- cells were either infected with TBEV (blue bars) or treated with TM immediately after infection
(black bars). At the indicated time points virus yields were measured (PFU/ml). b Tunicamycin treatment of TBEV infected cells led to early IFNβ induction.
Total RNA from MEF Ifnar-/- infected as above in a was extracted at the indicated time points and used as template for real-time qPCR using primers
specific for IFNβ. c Tunicamycin treatment led to early IRF3 phosphorylation. U2OS cells were infected with TBEV and treated with TM immediately after
infection. At the indicated time points the total protein content was extracted and subjected to immunoblotting with the indicated antibodies.
d Tunicamycin treatment led to early IRF3 nuclear translocation. U2OS cells were infected with TBEV and treated with TM immediately after infection. At
the indicated time points, cells were fixed and stained for IRF3 (AlexaFluor 488, green) and dsRNA (AlexaFluor 594, red). Scale bar= 10 μm.
e Quantification of IRF3 translocation following TBEV infection and Tunicamycin treatment. Cells treated as in d were manually quantified for IRF3 nuclear
translocation at each time point. The graph shows the results from two independent experiments, ∼ 200 cells for each time point. f, g Tunicamycin
treatment of TBEV infected cells led to early ISG induction. Total RNA from U2OS cells infected with TBEV moi= 1 was extracted at the indicated time
points and used as template for real-time qPCR using primers specific for IFIT1 or Viperin. Values of ISG mRNA from mock-infected cells treated with
Tunicamycin were also indicated (magenta bars). h Tunicamycin treatment of TBEV infected cells led an early ISG signature. Transcriptome analysis of
cells infected with TBEV compared with infected and treated with TM was performed at 8 h.p.i. in U2OS cells. The cluster of 39 genes differentially
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described in the legend to Fig. 1. Source data are provided as a Source Data file
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(Supplementary Fig. 2). Therefore, an ISG antiviral signature
characterized the early response triggered by the UPR during
TBEV infection.
The UPR-dependent anti-TBEV response is IRE1 and IRF3/
RIG-I dependent. The UPR activates three signaling pathways
mediated by the ER transmembrane proteins ATF6, IRE1, and
PERK. Each of them was targeted by RNAi to investigate their
involvement in antiviral signaling following TBEV infection.
U2OS cells were treated with siRNA (IRE1 and ATF6) or with
shRNA (PERK) to deplete cells of the respective proteins. As
shown in Fig. 4a–d, depletion of PERK or ATF6 did not result in
significant changes of viral yields. Depletion of PERK was also
obtained by siRNA transfection with similar results (Supple-
mentary Fig. 3A and 3B). Conversely, depletion of IRE1 resulted
in a higher TBEV titer (Fig. 4e, f) and enhanced TBEV RNA
levels (Fig. 4g), but not IFNβ mRNA (Fig. 4h). Therefore, the
IRE1 pathway appears principally responsible for UPR-mediated
antiviral signaling for TBEV. Indeed, IRE1 depletion partially
rescued replication of TBEV following TM treatment (Fig. 4i, j).
From previous studies it was discovered that the IFN response
against TBEV infection depends on the activity of the PRR RIG-I
leading to IRF3 induction15. In order to understand if the anti-
viral activity triggered through IRE1 was dependent on IRF3,
U2OS cells were treated with a siRNA against IRF3 and then
infected and subjected to TM treatment. As shown in Fig. 4k, l,
IRF3 depletion almost completely rescued viral replication in
conditions of UPR priming. Hence, the UPR primes infected cells
for IRF3-mediated antiviral activity. Depletion of RIG-I also
partially rescued TBEV replication indicating that PRR sensing
contributes to this pathway together with IRE1 (Fig. 4m, n). One
possible mechanism could be related to the RNAse activity of
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loading control (a). At the indicated time points, supernatants from infected cells were used to infect Vero cells to measure virus yields (b). c, d ATF6
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immunoblotting at 16 and 24 h.p.i. Actin is the protein loading control (c). At the indicated time points, supernatants from infected cells were used to infect
Vero cells to measure virus yields (d). e, f IRE1 depletion increased TBEV yields. U2OS cells were treated as above (c, d) with siIRE1. g, h IRE1 depletion
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IRF3 depletion. Immunoblot for IRF3 and TBEV RNA quantification was performed at 24 h.p.i.m, n RIG-I depletion partially rescued TBEV replication in TM-
treated cells. U2OS cells were treated as above (i, j) in conditions of RIG-I depletion. Immunoblot for RIG-I and TBEV RNA quantification was performed at
24 h.p.i. Statistics as already described in the legend to Fig. 1. Source data are provided as a Source Data file
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IRE1, which leads to Xbp1 splicing and IRE1-dependent decay of
RNA (RIDD) activity. Xbp1 transcription factor has been shown
to directly activate IFN, while the RIDD activity has been pro-
posed to generate substrates for RIG-I signaling24,25. However,
pretreatment of TBEV infected cells with 4μ8C, a specific inhi-
bitor of IRE1 RNAse activity capable of inhibiting Xbp1 splicing
(Supplementary Fig. 3C), didn’t show any modulation of virus
infectivity (Supplementary Fig. 3D). These data indicate that
IRE1-mediated pathways other than Xbp1 splicing and RIDD
activity need to be considered to explain the UPR-dependent
antiviral signaling induced by TBEV infection.
Other flaviviruses, such as WNV, DENV2, and ZIKV, which
have been shown previously to be inhibited by early induction of
the UPR with TM (Fig. 2g–l), also respond in terms of rescued
viral replication in conditions of IRF3 depletion (Supplementary
Fig. 4A–4F). These experiments reinforce the notion that there is
a causal link between virus-induced ER stress and innate immune
sensing and that this feature is shared among different
flaviviruses. However, WNV replication inhibited by TM could
not be rescued in IRE1 depleted cells (Supplementary Fig. 4G and
4H). This observation indicates that while TBEV appears to
depend principally on the IRE1 pathway, other flaviviruses may
require the contribution of ATF6 or PERK.
Discussion
In this work, virus-induced UPR is shown to play a pivotal role in
the cell intrinsic innate antiviral response to flaviviruses. UPR and
innate sensing have been shown previously to synergize following
sterile stimulation10–13. However, evidence of this mechanism in
infected cells is lacking. The experimental evidence presented
here in the context of flavivirus infection points to a direct role of
the UPR to trigger a suboptimal activation of the IRF3 pathway,
which synergizes with PRR signaling to mount a potent antiviral
defense.
This work stems from previous observations that identified a
delayed IFN response following flavivirus infection14,15. Tran-
scriptome analysis of TBEV infected cells identified the UPR and
ER stress pathways as early responses of the cell to infection prior
to the IFN response. Similar findings were recently observed for
cells of neuronal origin infected with TBEV26. Hence, a temporal
analysis of UPR activation was performed to better understand
the order of cellular events that follow infection.
ATF6 nuclear translocation, following TBEV infection,
increased from 8 h.p.i. (Fig. 1i) confirming earlier observations
taken at 24 h.p.i.27. ATF6-dependent genes, such as Xbp1 and BiP,
also increased following infection (Fig. 1e, j). However, ATF6
depletion did not affect viral yields indicating that the ATF6
pathway is dispensable during infection (Fig. 4c, d). These
observations are consistent with DENV2 infection, which has
been shown to induce ATF6 nuclear translocation but was not
affected in ATF6 MEF knockouts28,29. Conversely, WNVKUN
infection, which also induces activation of the ATF6 branch of the
UPR at 12–18 h.p.i., showed decreased titers in ATF6-/-
MEFs30,31. ATF6 could have a cytoprotective role during milder
infections such as WNVKUN, while remains nonessential for more
pathogenic viruses such as DENV or TBEV. Indeed, a more lethal
strain of WNV has been shown to degrade ATF6 in a
proteasome-dependent manner32.
PERK phosphorylation, following TBEV infection, was visible
from 8 h.p.i. and eIF2α phosphorylation increased from 12 h.p.i.
(Fig. 1h). PERK depletion did not affect viral yields (Fig. 4a, b).
Conversely, WNVKUN infection did not induce strong phos-
phorylation of eIF2α, but infection of PERK KO cells led to an
increase of viral replication30. Similarly, PERK was shown to
negatively regulate DENV2 infection and induced
phosphorylation of eIF2α at 9 h.p.i., but at later time the phos-
phorylation of this factor was negatively regulated28. Another
report suggested a proviral role of PERK in DENV2 infection
with decreased virus titers in PERK-/- MEFs33. These data suggest
that TBEV, WNV, and DENV2 are regulating the PERK pathway
during infection, but its role is still a matter of debate and may
depend upon the cell type used or to the virus with differential
kinetic properties.
Xbp1 splicing during TBEV infection was activated as early as
12 h.p.i. (Fig. 1f). Earlier studies already demonstrated
Xbp1 splicing following TBEV infection, but only at later time
points27. Other Flaviviruses, such as WNVKUN, DENV2, and JEV,
also activate Xbp1 splicing early during infection28–30. The
transcription activity of Xbp1s is preserved in TBEV infected
cells, as demonstrated by the activation of its target genes
DNAJB9 and DNAJC3 (Supplementary Fig. 1A and 1B). This is in
agreement with what has been observed for JEV and DENV229.
Notably, IRE1 depletion resulted in an increase of TBEV titers
suggesting a role in antiviral signaling (Fig. 4e, f). These data are
in contrast to DENV infection that has been shown to yield
significant lower infectious virus in IRE1-/- MEFs28. However,
besides being different viruses that adapted differently to the host,
genetic knockout may activate compensatory pathways that
influence the outcome of the assay. Interestingly, several reports
indicate that targeting the Xbp1 pathway downstream of IRE1
had no effect on the infection by DENV, JEV, and
WNVKUN28,30,32. Also for TBEV, the use of 4μ8C, a specific
inhibitor of the RNAse activity of IRE1 required for
Xbp1 splicing, did not impact infectivity suggesting alternative
explanations (Supplementary Fig. 3C and 3D).
Next, the causal link between the UPR and innate responses
was explored. UPR induction in the context of TBEV infection
led to phosphorylation of IRF3 and its nuclear translocation at
early time points (Fig. 3c–e). Transcriptome analysis following
viral infection and UPR induction caused an early signature of
innate response with the activation of several ISGs with antiviral
activity (see heatmap in Fig. 3h and Supplementary Fig. 2). These
observations point to a direct role of the UPR, in particular
through the IRE1 arm for TBEV, to trigger a suboptimal acti-
vation of the IFNβ pathway, which then synergizes with PRR
signaling to mount antiviral defenses. Indeed, depletion of IRE1
or IRF3/RIG-I in the context of UPR induction preserved from
the antiviral effect (Fig. 4). IRF3 depletion induced a rescue of
viral replication also for WNV, DENV2, and ZIKV, indicating a
general mechanism of UPR priming of antiviral innate immunity.
However, IRE1 dependence could be demonstrate for TBEV, but
not for WNV (Supplementary Fig. 4G and 4H). This observation
is in line with the differences in UPR response among flaviviruses
as mentioned above and will require further analysis.
PRR signaling is believed to depend on the unmasking of
specific viral PAMPs during infection, particularly RNA replica-
tion intermediates for flaviviruses15. Disruption of these com-
partments that allow PRR access to agonist RNA is therefore
required for full activation of the IFN response. It is possible to
conceive that the UPR also triggers the modification of mem-
branes or membrane-associated protein complexes that even-
tually unmask the viral RNAs allowing PRR function. Recent loss-
of-function screens identified novel ER-associated factors
required for flavivirus replication, which could provide hints on
the cellular factors involved in this process34,35.
To conclude, several lines of evidence point to a direct rela-
tionship between the UPR and PRR-mediated activation of cell
intrinsic innate antiviral signaling. Independent pathways coop-
erate to respond to viral infection and to overcome viral sub-
version strategies in the incessant battle between flaviviruses and
the host cell.
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Materials and methods
Cells and viruses. TBEV represents a good model of the Flavivirus genus because
it is easily manipulated leading to robust infection in vitro. Furthermore, U2OS
cells were shown previously to maintain an intact PRR-IFNβ signaling pathway
with respect to TBEV infection15.
Vero clone E6 (ATCC C1008) and human osteosarcoma U2OS cells (ATCC
HTB-96) were grown under standard conditions in Dulbecco’s modified Eagle
medium (DMEM) supplemented with 10% fetal bovine serum. Primary murine
embryonic fibroblasts (MEF Ifnar-/-) from mice lacking the α-chain of the IFN-α/β
receptor on a B6 background were kindly provided by U. Kalinke (TWINCORE
Germany). Pregnant female mice at 13–14 days of gestation were sacrificed and
uterus were removed with the help of forceps and washed with sterile PBS to
remove blood. Embryos were carefully separated from the uterus of pregnant mice
at 13–14 days of gestation and their head and liver was removed. Each embryo was
minced, treated with trypsin EDTA and plated in growth medium. Low-passage
MEFs were used for the experiments. Wild-type MEF were similarly obtained from
isogenic B6 animals. Animal care and treatments were conducted in conformity
with institutional guidelines in compliance with national and international laws
and policies.
Working stocks of TBEV (strain Neudoerfl), West Nile virus (strain NY99),
Dengue virus type 2 (strain New Guinea), and Zika virus (strain Uganda #976)
were routinely propagated and titrated on Vero E6 cells.
UPR inducers Tunicamycin or Thapsigargin (Sigma-Aldrich) were added to
cells 1 h after infection (0 h.p.i.). IRE1 Inhibitor 4μ8C (Tocris) was added to U2OS
at 0 h.p.i. at a concentration of 30 μM.
LV Production and shRNA delivery. Lentiviral silencing vectors were derived
from pLKO.1 TRC (Addgene). The control short hairpin RNA (shCTRL) was the
pLKO.1 scramble from Addgene. For PERK targeting, a specific sequence was
designed and cloned into pLKO.1 TRC (shPERK) using the oligonucleotides 5′-CC
GGGGAACGACCTGAAGCTATAAACTGCAGTTTATAGCTTCAGGTCGTTC
CTTTTTG-3′ and 5′-AATTCAAAAAGGAACGACCTGAAGCTATAAACTGCA
GTTTATAGCTTCAGGTCGTTCC-3′.
Packaging in HEK 293T cells was performed according to standard procedures
using the packaging plasmid psPAX2 and pMD2.G (Addgene). Cell supernatants
were filtered and kept at −80 °C until use. U2OS cells were transduced in presence
of polybrene (hexadimethrine bromide, Sigma-Aldrich) following manufacturer’s
protocol. Transduced cells were selected using 2 μg/ml puromycin.
RNA interference. Pools of small interfering RNAs (siRNAs) were obtained from
Dharmacon. ON-TARGET plus Nontargeting Pool was used as a control in all
experiments. ON-TARGET plus SMARTpool siRNA was used for the depletion of
ATF6 IRE1, PERK, IRF3, and RIG-I. U2OS cells were transfected with siRNAs at a
concentration of 100 nM, using Lipofectamine RNAiMAX transfection Reagent
(Invitrogen) according to the manufacturer’s instructions.
Western-blotting and immunofluorescence. For immunoblotting, whole-cell
lysates were resolved by SDS-PAGE and blotted onto nitrocellulose membranes.
The membranes were blocked in 4% nonfat milk in Tris-buffered saline (TBS) plus
0.1% Tween 20 (TBST), followed by incubation with the primary antibody diluted
in the same solution at 4 °C overnight. After washing three times with TBST,
secondary horseradish peroxidase (HRP)-conjugated antibodies were incubated for
1 h at room temperature. The blots were developed using a chemioluminescent
HRP substrate (Millipore). For immunofluorescence (IF), cells were washed with
PBS, fixed with 4% paraformaldehyde for 15 min, incubated for 5 min with 100
mM glycine, and permeabilized with 0.1% Triton X-100 for 5 min. Subsequently,
the cells were incubated at 37 °C for 30 min with PBS, 1% bovine serum albumin,
and 0.1% Tween 20 before incubation with antibodies. The coverslips were rinsed
three times with PBS, 0.1% Tween 20 (washing solution) and incubated for 1 h with
secondary antibodies. The coverslips were finally washed three times with washing
solution and mounted on slides using Vectashield mounting medium (Vector
Laboratories). Fluorescence images of fixed cells were captured on a Zeiss LSM510
Meta confocal microscope with a 63 × numerical-aperture 1.4 Plan-Apochromat oil
objective. Further details can be found in previous publications36,37. The following
antibodies were used in this study: a rabbit polyclonal against the TBEV E protein
produced in our laboratory following immunization with the inactivated virions
(1:100 IF, 1:1000 WB); a rabbit polyclonal against TBEV prM kindly provided by
Franz Heinz, Vienna (1:100 WB); a rabbit polyclonal against human eIF2α from
SCBT (1:100 WB, cat.no. sc-11386); a rabbit polyclonal against phosphorylated
(Ser51) human eIF2α from Cell Signaling (1:500 WB, cat.no. 9721); a rabbit
polyclonal against human PERK from SCBT (1:500 WB, cat.no. sc-13073); a rabbit
monoclonal against human PERK from Cell Signaling (1:1000 WB, cat.no. 3192); a
rabbit polyclonal against phosphorylated (T981) human PERK from SCBT (1:200
WB, cat.no. sc-32577); a mouse monoclonal against human PKR from SCBT (1:200
WB, cat.no. sc-6282); a mouse monoclonal against human β-catenin from BD
Transduction Lab (1:2000 WB, cat.no. 610153); a mouse monoclonal against
human β-actin conjugated with peroxidase from Sigma-Aldrich (1:50000 WB,
A3854); a rabbit monoclonal against IRF3 from Cell Signaling (1:1000 WB, cat.no.
4302); a mouse monoclonal against dsRNA from English & Scientific Consulting
(1:100 IF, cat.no. J2-1101) a rabbit monoclonal against phospho-IRF3 from Cell
Signaling (1:500 WB, cat.no. 4947); a mouse monoclonal against ATF6 from
Abcam (1:500 WB, cat.no. ab122897); a rabbit monoclonal against IRE1 from Cell
Signaling (1:1000 WB, cat.no. 3294); a mouse monoclonal against RIG-I from
Adipogen (WB 1:500, cat. No. AG-20B-0009). Secondary antibodies conjugated
with AlexaFluor 488/594 were from Life Technologies (1:500 IF, cat.no. anti-mouse
594 A21207 and anti-rabbit 488 A-21206) and peroxidase conjugates from Dako
(1:5000 WB, cat.no. anti-rabbit P0448 and anti-mouse P0447).
Real-time quantitative reverse transcription PCR. For real-time quantitative
reverse transcription PCR (qPCR) total cellular RNA was extracted with the UPzol
according to the manufacturer’s protocol (Biotechrabbit) and treated with DNase I
(Invitrogen). 500 ng were then reverse-transcribed with random primers and M-
MLV Reverse Transcriptase (Invitrogen). Quantification of mRNA was obtained by
real-time PCR using the Kapa Sybr fast qPCR kit on a CFX96 Bio-Rad thermo-
cycler. Primers for amplification are listed in Supplementary Table 1.
Transcriptome analysis by RNAseq. For the first transcriptome analysis (Fig. 1)
Human U2OS cells were infected with TBEV at a moi of 1 PFU/cell. Cells were
lysed using UPzol (Biotechrabbit) and total RNA was extracted at time 0, 10, and
24 h post-infection (h.p.i.). For the second transcriptome analysis (Fig. 3) U2OS
cells were infected with TBEV at a moi of 1 PFU/cell and after 1 h media were
replaced with normal growth medium or DMEM plus TM. Cells were lysed with
UPzol and total RNA was extracted from each condition at 0 and 8 h.p.i.
Quality of extracted RNA was checked by gel electrophoresis (ribosomal 18S
and 28S), spectrophotometric analysis (260/280 > 1.8), and Agilent bioanalyzer
(RNA integrity number, RIN ≥ 8). All cDNA libraries of polyA-containing mRNA
molecules were prepared using Illumina TruSeq standard protocol. Libraries were
pooled and sequenced on two different Illumina Platforms. The first run was
performed on Hiseq2000 4-plex run single reads, 50 bp reads, while the second run
was performed on HiscanSQ 8-plex run pair-end reads, 2 × 100 bp reads. All data
were subjected to quality control using FastQC software. Single reads were mapped
against the human genome RNA reference from NCBI using CLCbio software,
while pair-end reads were mapped against Homo sapiens GRCh38.77 reference
from UCSC using STAR software38. Bioconductor pakages DESeq2 version
1.18.139 and IHW40 version 1.6.0 in the framework of R software version 3.4.3 was
used to perform differential gene expression analysis of cells infected with TBEV at
24versus 10 h.p.i and cells infected with TBEV and treated with TM at 8 h.p.i versus
uninfected cells treated with TM at the same time point. The package is based on
the negative binomial distribution (NB) to model the gene reads counts and
shrinkage estimator to estimate the per-gene NB dispersion parameters.
Specifically, rounded gene counts were used as input and the per-gene NB
dispersion parameter was estimated using the function DESeq for DESEQ2. The
RNA-seq workflow recommendations41 were used to detect outlier data after
normalization and to improve testing power, while maintaining type I error rates
Independent Hypothesis Weighting was used as multiple testing procedure.
Estimated p-values for each gene were adjusted using the Benjamini–Hochberg
method42. Genes with adjusted P < 0.05 and absolute logarithmic base twofold
change >1 were selected. Data were finally analysed with the IPA software.
Statistics. Typically three independent experiments in triplicate repeats were
conducted for each condition examined. Average values are shown with standard
deviation and p-values, measured with a paired two-tailed t-test. Only significant p-
values are indicated by the asterisks above the graphs (**p < 0.01 highly significant;
*p < 0.05 significant). Where asterisks are missing the differences are calculated as
nonsignificant (n.s).
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
Data underlying Figs. 1 B–J, 2 A–L, 3 A–C and E–H, 4 A–N, Supplementary Figs. 1A, B
and D–F, 2 A–F, 3 A–H, and 4 A–H are provided as Source Data files. All other data are
available from the corresponding author upon reasonable requests. RNAseq data have
been deposited with links to BioProject accession number PRJNA474353 in the NCBI
BioProject database [https://www.ncbi.nlm.nih.gov/bioproject/]. Sequence Read Archive
(SRA) submission: SUB4111543—1st of June 2018, SRA accession: SRP149625.
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Appendix 2: Interferon-Stimulated Genes identified in the differential analysis 
from the Whole genome transcriptome analysis (Fig.13) 
 ISG  Description Characteristics References 
1 ISG15 ISG15 Ubiquitin-Like 
Modifier 
• IFN-induced 
• Antiviral 
Dai et al., 2011 
2 IL22RA1 Interleukin 22 
Receptor Subunit 
Alpha 1 
IFN-induced  
3 IFI6 Interferon Alpha 
Inducible Protein 6 
• IFN-induced	
• Antiviral	 Richardson et al., 2018 
4 IFI44L Interferon Induced 
Protein 44 like 
• IFN-induced	
• Antiviral 	 • Schoggins et al., 2011 
• Metz et al., 
2013 
5 IFI44 Interferon Induced 
Protein 44 
• IFN-induced	
• Antiviral 	
• Alias: MTAP44	 • Hallen et al., 2007 • Power et al., 
2015 
• Carlton-Smith 
and Elliot, 2012 
6 RP5-968D22.1 ncRNA   
7 CREG2 Cellular Repressor Of 
E1A Stimulated Genes 
2 
  
8 IFIH1 MDA5 • IFN-induced	
• Antiviral 	 Dias et al., 2019 
9 ACKR3 Atypical Chemokine 
Receptor 3/ CXCR7 
 
Acts as co-receptor 
with CXCR4 for a 
restricted number of 
HIV isolates 
• nexprot.org 
• Chevingné et 
al., 2014 
10 RP11-221J22.1 ncRNA   
11 ZPLD1 Zona Pellucida Like 
Domain Containing 1 
  
12 PARP9 Poly (ADP-Ribose) 
Polymerase Family 
Member 9 
Involved in interferon 
signaling 
 
13 PDGFRA Platelet Derived 
Growth Factor 
Receptor Alpha 
  
14 CXCL8 C-X-C Motif 
Chemokine Ligand 8, 
IL8 
IFN-induced  
15 HERC6 HECT And RLD 
Domain Containing E3 
Ubiquitin Protein 
  
		 112	
Ligase Family 
Member 6 
16 DDX60 DExD/H-Box Helicase 
60 
Antiviral  • Miyashita et 
al., 2011 
• Schoggins et 
al., 2011 
• Oshiumi et al., 
2015 
17 GFPT2 Glutamine-Fructose-
6-Phosphate 
Transaminase 2 
  
18 SAMD9 SAM Domain-
Containing Protein 9  
• IFN-induced	
• Antiviral 	 • Liu and McFadden, 
2015 
• Meng et al., 
2018 
19 SAMD9L SAM Domain-
Containing Protein 9 
like 
• IFN-induced 
• Antiviral  
Meng et al., 2018 
20 ZC3HAV1 Zinc Finger CCCH-
Type Containing, 
Antiviral 1 
• Antiviral  
• Aliases: PARP13, 
ZAP 
• Lee et al., 2013 
• Ohainle et al., 
2018 
21 ZFPM2-AS1 ncRNA   
22 PARP10 Poly (ADP-Ribose) 
Polymerase Family 
Member 10 
Antiviral Atasheva et al., 
2014 
23 DDX58 RIG-I • IFN-induced 
• Antiviral 
Kato et al., 2006 
24 BATF2 Basic Leucine Zipper 
ATF-Like Transcription 
Factor 2 
  
25 CXCL12 C-X-C Motif 
Chemokine Ligand 12, 
SDF1 
  
26 OASL 2'-5'-Oligoadenylate 
Synthetase Like 
• IFN-induced 
• Antiviral 
• Zhu et al., 2014 
• Dhar et al., 
2015 
27 IRF9 Interferon Regulatory 
Factor 9 
• Constitutive and 
IFN-inducible 
• Mostly acts as part 
of the ISGF3 
complex 
• Kimura et al., 
1996 
• Kraus et al., 
2003 
• Huber et al., 
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2017 
 
28 TTC6 Tetratricopeptide 
Repeat Domain 6 
  
29 BCL2A1 BCL2 Related Protein 
A1 
  
30 RP11-401O9.4 ncRNA   
31 HELZ2 Helicase with Zinc 
Finger 2, 
Transcriptional 
Coactivator 
• IFN-induced 
• Antiviral (DENV) 
Fusco et al., 2017 
32 S1PR5 Sphingosine-1-
Phosphate Receptor 5 
  
33 USP18 Ubiquitin Specific 
Peptidase 18, ISG15-
Specific-Processing 
Protease 
• IFN-induced 
• Antiviral (some DNA 
viruses) 
Zhang et al., 2016 
34 USP41 Ubiquitin Specific 
Peptidase 41 
  
35 ZNRF3 E3 Ubiquitin-Protein 
Ligase ZNRF3 
  
36 CPSF1P1 Cleavage and 
Polyadenylation 
Specific Factor 1 
Pseudogene 1 
  
37 FP671120.6 ncRNA   
38 FP236383.9 ncRNA   
39 FP236383.3 ncRNA   
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